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4Abstract
Personalized nanomedicine has been shown to provide advantages over tradi-
tional clinical imaging, diagnosis, and conventional medical treatment. Using 
nanoparticles can enhance and clarify the clinical targeting and imaging, and 
lead them exactly to the place in the body that is the goal of treatment. At the 
same time, one can reduce the side effects that usually occur in the parts of the 
body that are not targets for treatment. 
Nanoparticles are of a size that can penetrate into cells. Their surface func-
tionalization offers a way to increase their sensitivity when detecting target 
molecules. In addition, it increases the potential for flexibility in particle de-
sign, their therapeutic function, and variation possibilities in diagnostics. 
Mesoporous nanoparticles of amorphous silica have attractive physical and 
chemical characteristics such as particle morphology, controllable pore size, 
and high surface area and pore volume. Additionally, the surface functionaliza-
tion of silica nanoparticles is relatively straightforward, which enables optimi-
zation of the interaction between the particles and the biological system.
The main goal of this study was to prepare traceable and targetable silica na-
noparticles for medical applications with a special focus on particle dispersion 
stability, biocompatibility, and targeting capabilities. 
Nanoparticle properties are highly particle-size dependent and a good dis-
persion stability is a prerequisite for active therapeutic and diagnostic agents. 
In the study it was shown that traceable streptavidin-conjugated silica nano-
particles which exhibit a good dispersibility could be obtained by the suitable 
choice of a proper surface functionalization route.
Theranostic nanoparticles should exhibit sufficient hydrolytic stability to ef-
fectively carry the medicine to the target cells after which they should disinte-
grate and dissolve. Furthermore, the surface groups should stay at the particle 
surface until the particle has been internalized by the cell in order to optimize 
cell specificity. Model particles with fluorescently-labeled regions were tested in 
vitro using light microscopy and image processing technology, which allowed a 
detailed study of the disintegration and dissolution process. The study showed 
that nanoparticles degrade more slowly outside, as compared to inside the cell.
The main advantage of theranostic agents is their successful targeting in 
vitro and in vivo. Non-porous nanoparticles using monoclonal antibodies as 
guiding ligands were tested in vitro in order to follow their targeting ability 
and internalization. In addition to the targeting that was found successful, a 
specific internalization route for the particles could be detected. In the last part 
of the study, the objective was to clarify the feasibility of traceable mesoporous 
silica nanoparticles, loaded with a hydrophobic cancer drug, being applied for 
targeted drug delivery in vitro and in vivo. Particles were provided with a small 
molecular targeting ligand. In the study a significantly higher therapeutic effect 
5could be achieved with nanoparticles compared to free drug. The nanoparti-
cles were biocompatible and stayed in the tumor for a longer time than a free 
medicine did, before being eliminated by renal excretion. Overall, the results 
showed that mesoporous silica nanoparticles are biocompatible, biodegradable 
drug carriers and that cell specificity can be achieved both in vitro and in vivo.
6Referat
Individuellt skräddarsydd nanomedicin har visat sig ha fördelar jämfört med 
traditionell klinisk bildåtergivning, diagnos och konventionell medicinsk be-
handling. Med hjälp av nanopartiklar kan man effektivera och precisera mål-
sökningen och bildåtergivningen för de ämnen som är viktiga för den kliniska 
behandlingen och leda dem exakt till det ställe i kroppen som är målet för be-
handlingen. Samtidigt kan man minska de sidoeffekter som vanligtvis åsamkas 
de delar av kroppen som inte är mål för behandling. 
Nanopartiklar har en sådan storlek att de kan tränga sig in i celler. Funk-
tionalisering av dem erbjuder ett sätt att öka känsligheten när man detekterar 
målmolekylerna. Dessutom ökar möjligheterna till flexibilitet i partiklarnas 
design, deras terapeutiska funktion och variationsmöjligheterna i diagnosti-
ken. Mesoporösa nanopartiklar av amorf kiseldioxid har attraktiva fysikalisk-
kemiska särdrag såsom en kontrollerbar partikelmorfologi och porstorlek samt 
hög ytarea och porvolym. Dessutom kan kiseldioxidnanopartiklarna relativt 
lätt ytfunktionaliseras, vilket möjliggör optimering av växelverkningarna mel-
lan partiklarna och det biologiska systemet. 
Det huvudsakliga målet för denna studie har varit att tillverka spårbara och 
målsökande kiseldioxidbaserade nanopartiklar för medicinska tillämpningar 
med speciell focus på partiklarnas dispersionsstabilitet, biokompatibilitet och 
målsökningsförmåga.
Nanopartiklarnas egenskaper är mycket beroende av partikelstorleken och 
en god dispersionsstabilitet är en förutsättning för ett aktivt terapi- och diag-
nosmedel. I studien visades att spårbara streptavidinkonjugerade kiseldioxid 
nanopartiklar och vilka uppvisar en god dispergerbarhet kunde erhållas genom 
ett lämpligt val av ytfunktionaliseringsrutt.
Teranostiska nanopartiklar bör uppvisa en tillräckligt för att effektivt kun-
na bära läkemedel till målcellerna varefter de bör sönderfalla och upplösas. 
Dessutom bör ytgrupperna hållas på partikelytan tills partikeln har blivit in-
ternaliserad av cellen för att optimera cellspecificiteten. Modellpartiklar med 
fluorescent märkta regioner undersöktes in vitro med hjälp av ljusmikroskopi 
och bildbehandlingsteknik, vilket möjliggjorde en detaljerad studie av sönder-
falls- och upplösningsprocessen. Studien visade att nanopartiklarna sönderfal-
ler långsammare utanför jämfört med innanför cellen.
Den främsta fördelen med teranostiska preparat är deras lyckade målsök-
ning in vitro och in vivo. Icke-porösa nanopartiklar som använde monoklonala 
antikroppar som guidningsmedel undersöktes in vitro för att följa deras mål-
sökningsförmåga och internalisering. Förutom att målsökningen konstaterades 
framgångsrik, kunde en specific internaliseringsrutt för partiklarna påvisas. 
Slutligen undersöktes möjligheten att använda spårbara mesoporösa kiseldi-
oxidnanopartiklar laddade med en hydrofob cancermedicin för målsökande 
7läkemedelsfrisättning in vitro och in vivo. Partiklarna försågs med en småmo-
lekylär målsökande ligand. En klart högre terapeutisk effekt kunde uppnås med 
nanopartiklarna jämfört med fri drog. Nanopartiklarna var biokompatibla och 
stannade i tumören en längre tid än en fri medicin, innan de eliminerades ge-
nom utsöndring via njurarna. Sammantaget visar resultaten att mesoporösa 
kiseldioxid nanopartiklar är biokompatibla, biodegraderbara läkemedelsbärare 
och att cellspecificitet kan uppnås såväl in vitro som in vivo. 
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Symbols and abbreviations
αOH Amount of surface silanols (in μmol/m2 or nm2)
Γ Surface excess
ζ Zeta potential
θ Scattering angle 
κ-1 Thickness of the diffuse layer
Ψ0 Surface potential
AFM Atomic Force Microscopy
APTS (3-Aminopropyl)triethoxysilane
APTMS (3-Aminopropyl)trimethoxysilane
BET Brunauer-Emmett-Teller theory for surface area determination
BJH Barrett-Joyner-Halenda for pore size determination
CPP Critical Packing Parameter (of surfactants)
CTAB Cetyltrimethylammonium bromide 
CTAC Cetyltrimethylammonium chloride 
d Diameter of a sphere
Da Dalton
DAPT A hydrophopic substance used for the treatment of various types of cancers, 
({N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycinet-butyl ester})
DCC N,N’-dicyclohexylcarbodiimide
DLS Dynamic Light Scattering
FA Folic Acid
FITC Fluorescein isothiocyanate 
GA Glutaraldehyde
GSI Gamma Secretase Inhibitor
EDC 1-Ethyl-3-(3-(dimethylamino)propyl)-carbodiimide
ex vivo from latin: “out of the living”
EPR Enhanced Permeability and Retention (effect on the tumor site)
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid buffer
IEP Isoelectric point 
in vitro from Latin: “in living”, i.e. under physiological conditions
in vivo from Latin: “in glass”, i.e. under simulated physiological conditions
i.v. intravenous
IUPAC International Union of Pure and Applied Chemistry
KD Dissociation constant
M41S The family of mesoporous materials introduced by Mobil Oil
MAb Monoclonal Antibody
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MCM-41 2-dimensional hexagonally ordered (p6m) mesoporous silica material syn-
thetized with cationic surfactants as structure-directing agents, first reported 
by a research group at the Mobil Oil Company, USA 
MCM Mobil Composition of Matter 
MES Morpholinoethanesulfonic acid buffer
NIR Near Infrared
NHS N-hydroxysuccinimide
NLDFT Non-local density functional theory
MRI Magnetic resonance imaging
MSN Mesoporous silica nanoparticle
NMR Nuclear magnetic resonance
PEG Polyethyleneglycol
PEI Poly(ethyleneimine)
PET Positron Emission Tomography
pKa Acidity constant 
p.t. peritumoral
PZC Point of zero charge
RT Room temperature (298 K)
ROI Region of Interest (in confocal imaging)
SAOS-2 cells Human sarcoma osteogenic cells
SAXS/SAXD Small Angle X-ray Scattering/ Small Angle X-ray Diffraction
scFv Single-chain Fragment variable (antibody) 
SEM Scanning electron microscopy
SBF Simulated Body Fluid
STV Streptavidin
SUCC Succinic acid
SSA Specific Surface Area per unit of mass 
Sulfo-NHS N-hydroxysulfosuccinimide 
Sulfo-SMCC Sulfo-succinimidyl-(4-N-maleimidomethyl) cyclohexane-1-carboxylate
TEM Transmission electron microscopy
TEOS Tetraethyl orthosilicate
TMB Trimethylbelzene
TMOS Tetramethyl orthosilicate 
TRITC Tetramethylrhodamine-5-(and 6)-isothiocyanate 
Ue Electrohoretic mobility
PBS Phosphate buffered saline
RES Reticulo-endothelial system 
XRD X-Ray Diffraction
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Introduction
Personalized nanomedicine aims on developing tailored approaches to dis-
ease prevention and care. Nanomedicine has paved a way for improved disease 
treatment strategies enabling targeted imaging, diagnosis, and treatment.
Nanoparticles have size that matches the scale of the molecular substrates 
of personalized medicine;1 their functionalization provides a way for increased 
sensitivity in detecting and binding with target molecules, and flexibility in the 
design and function of therapeutics and diagnostics. Theranostic nanoparti-
cles can be utilized diagnostically to assess the disease status, molecular profile, 
and treatment response, all having influence on the treatment strategies. Silica 
nanoparticles have high potential to be used for theranostics due to their ex-
ceptional features and good biocompatibility.2–6 Recently silica nanoparticles 
“Cornell dots” got approval from US Food and Drug administration (FDA) for 
the first in human clinical trial for targeted molecular imaging of cancer.7 
A flexible nanosized drug carrier platform consists of a general toolbox that 
is employed to design a drug delivery system for a defined purpose. The pre-
requisites for a flexible drug-delivery platform include a) the option of diverse 
surface functionalization, b) a high cell specificity and efficient cellular uptake, 
c) a low degree of premature leakage and the possibility for sustained and con-
trolled release of the drug, d) a low cytotoxicity of the carrier matrix itself, e) 
the ability to incorporate therapeutically sufficient amounts of drugs into the 
carrier, f) a good dispersibility of the carrier in biological prevailing conditions, 
and g) a low level of protein adsorption onto the carrier surface.8 
The bottom-up approach synthesis of silica nanoparticles enables prepara-
tion of nonporous and porous nanocarriers with various particle and pore di-
ameters and narrow particle size distribution. Mesoporous silica nanoparticles 
can be synthesized with high specific pore volumes and surface areas of 0.6–1 
cm3/g and 700–1000 m2/g, respectively. 
The relatively straightforward functionalization of silica surface allows prep-
aration of material with diverse surface chemistries allowing the particles to be 
readily adapted for specific applications. Silica nanoparticles can be functional-
ized to facilitate their targeting to specific sites, tracing, and to enable triggered 
release of therapeutic agents to target cells. Silica nanoparticles are capable of 
encapsulating high amounts of contrast agents that effectively increase the sen-
sitivity of imaging modalities to enable imaging at the molecular level.9–11 Load-
ing the targeted nanoparticles with therapeutic agents ensures high efficacy on 
the target site while lessening or eliminating potential off-target side effects.12 
The incorporation of cargo in silica nanoparticles is most often conducted as 
last step, enabling regulation of the drug concentration in the particles. This 
loading procedure is especially applicable for often poorly water- soluble can-
cer drugs. 
16
Moreover, amorphous silica is biocompatible, dissolves in aqueous solu-
tions and is actively degraded by cells. The material properties of silica allow 
regulation of carriers’ degradation profile in such a way that enables surface 
functionalities to stay attached to particle the times relevant for the particles’ 
reaching their target sites. The requirement for a good biocompatibility is deg-
radation and excretion of the carrier matrix from the body after particles have 
accomplished their task.4,13–19
Silica nanoparticle platform enables a flexible particle design where fea-
tures and functionalities can be combined to produce multifunctional delivery 
systems enabling targeting, drug delivery and diagnostics actions. This thesis 
evaluates the potential of silica nanoparticles in medical imaging and targeted 
drug delivery applications.
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Background
1. Sol-gel synthesis for fabrication of non-porous 
and porous silica nanoparticles
The sol-gel method is a one-step procedure to prepare nanosized nonporous 
and mesoporous silica nanoparticles in low temperatures and in mild chemical 
conditions with predetermined particle and pore size, and morphology. 
In 1968 Stöber et al. reported the formation of monodisperse nanoparticles 
by means of hydrolysis and polycondensation of silicates in alcoholic solutions 
catalyzed by alkali conditions. Under alkaline conditions silica solubility in-
creases rapidly and Ostwald ripening takes place, which allows well-controlled 
nucleation and growth rate leading to the synthesis of monodisperse silica par-
ticles. Ideally during the synthesis, a short initial burst of nucleation is followed 
by a uniform growth resulting in the synthesis of homogenous particles. In 
an alkaline solution silica species are negatively charged, where simultaneous 
highly diluted reaction conditions are used to avoid the inter-particle aggrega-
tion during the particle synthesis. During controlled regulation of conditions 
such as concentration of ammonia, water, the chosen type of silicon alkoxide, 
type of alcohol, and reaction temperature, the Stöber synthesis allows produc-
tion of monodisperse non-porous particles with a diameter ranging from 50 
nm to 2 µm.1 
In 1992 Kresge et al. at Mobil Oil Research successfully synthetized ordered 
mesoporous materials by employing isotropic supramolecular surfactant ag-
gregates as structure directing agents (SDAs) around which inorganic material 
can deposit through hydrolysis and condensation via sol-gel approach, finally 
forming a mesoscopically-ordered hybrid inorganic material. The original syn-
thesis of Mobil Composition of Matter No 41 or, broader speaking, the M41S 
family of mesoporous materials is based on the co-operative self-assembly of 
aluminosilicates or silicates and alkyltrimethylammonium-based cationic sur-
factants. The procedure principally follows the synthesis of zeolithe molecular 
sieves, with the exception that instead of using single molecules as templates, 
supramolecular surfactant structures are used as porogens. The pore size of 
zeolithes is restricted to about 1.5 nm, while using of supramolecular surfactant 
structures as structure directing agents allows the synthesis of M41S family 
of mesoporous materials with a remarkably larger pore size typically ranging 
from 1.5 to 10 nm. The removal of an organic structure-directing agent by ther-
mal calcination or chemical extraction reveals an ordered pore structure of in-
organic silica materials.2
According to the International Union of Pure and Applied Chemistry 
(IUPAC), mesopores are pores with a diameter ranging from 2–50 nm. The 
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mesoporous class of the M41S type of material has a well-defined pore size 
distribution with a pore diameter ranging from 1.5–10 nm and with high sur-
face areas (≥700 m2/g). The original members of M41S family consist of Mobil 
Composition of Matter No 41, MCM-41 with a hexagonal pore structure, of 
MCM-48 type material with cubic pore structure and of MCM-50 type mate-
rial with pillared lamellar structure (Figure 1). As part of this thesis, MCM-41-
type hexagonally ordered nanoparticles were studied.3
Grün et al. introduced a mesoporous particle synthesis, which is a modifica-
tion of the Stöber approach. The synthesis is carried out in alkaline conditions 
by using alcohol as a co-solvent and aqueous ammonia as a catalyzing agent. 
Grün et al., moreover, used cationic quartenary ammonium surfactants similar 
to the original M41S type of synthesis to synthesize the mesoporous MCM-41 
type particles located in the sub-micrometer size class.5 Furthermore, Cai et al. 
and Nooney et al. reported the importance of controlled nucleation and growth 
of the particles during synthesis. This could be achieved by applying lower sur-
factant concentrations in alkaline conditions for the synthesis of MCM-41 type 
material leading to a defined particle morphology and a size of less than 100 
nm.6–8 Generally, the synthesis of monodisperse silica nanoparticles has proved 
to require alkaline synthesis conditions, thus following the principles of the 
original Stöber synthesis. These selected examples indicate that mesoporous 
silica synthesis is highly dependent on reaction conditions but is very versatile 
with respect to particle size, for example, allowing synthesis of mesoporous 
particles in the size range of tens of nanometers up to several micrometers. 
Silica is a very versatile material also allowing synthesis of various nano-
particle types, those consisting of intrinsic silica and those consisting of silica 
composite materials. Already as early as in the 1970’s and 1980’s, the studies 
of Matijević et al. demonstrated the synthesis of core-shell type colloids.9 Ca-
ruso et al. introduced the principles of colloidal templating to prepare hollow 
Figure 1. Schematic presentation of the structures of the MCM41S family of 
mesoporous ordered materials: (A) MCM-41, (B) MCM-48, (C) MCM-50.4
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silica spheres in 1998.10 As the particle size is crucial in theranostics, efforts 
have been undertaken to develop the particle synthesis in the direction ena-
bling preparation of core-shell, hollow and enlarged-pore particles in nanosize. 
These extraordinary particle features provide a benefit of increased loading ca-
pacity of therapeutic agents, enabling loading of high molecular size cargos 
such as genes and proteins for example.11,12 However, generally many aspects in 
the particle synthesis of silica nanoparticles are still not well understood and 
need further research and optimization.
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2. Particle synthesis through sol-gel silica poly-
merization
In the sol-gel synthesis process the polymerization of silica proceeds in three 
steps. These steps are nucleation, growth, and aggregation. 
1. With particle formation by polymerization and nucleation, silica mono-
mers polymerize via dimers, trimers, etc. and will further form cyclic 
structures and reach the 3D form of condensed particles.
2. Particle growth and Ostwald ripening follows.
3. Particles aggregate into branched chains and networks leading to the 
forming of a gel.
The condensation process proceeds by first maximizing the number of 
Si–O–Si bonds and resulting in the number of terminal hydroxyl groups being 
minimized by internal condensation. This condensation includes a rapid ring-
formation into which the monomers further bind, leading to the formation 
of three-dimensional small particles. These formed particles are compact and 
have OH– -groups only on the particle surface. The further growth of the parti-
cles proceeds through Ostwald ripening resulting in particle size growth since 
particles diminish in numbers when smaller particles dissolve into monomers 
that then re-deposit on the larger less soluble particles. Both pH and the tem-
perature have an effect on the progress of particle growth. An overview of the 
polymerization process of silica in an aqueous solution can be seen in Figure 2.
Figure 2. An illustration of the sol-gel process.13
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The sol-gel process can be described by three equilibrium reactions (where 
R is an alkyl group).
In the hydrolysis reaction (eq. 1) alcoxide groups are replaced by hydrox-
yl groups. Hydrolysis is generally catalyzed by a base (NH3, NaOH) or min-
eral acid (HCl). In the subsequent condensation reactions siloxane bonds 
(Si–O–Si) are formed and with alcohol (eq. 2) and water (eq. 3) formed as by-
products. Because water and alkoxysilanes are immiscible, alcohol is often used 
as the homogenizing agent. The relative kinetics of the three equilibrium reac-
tions involved is regulated by several parameters such as pH, the type of silica 
precursor, H2O/Si molar ratio (r-value), temperature, co-solvents, and the solu-
bility of silica. 
Hydrolysis reaction-rate retardation is observed when the silicon alkoxide 
precursor molecular size is increased. This is caused by steric hindrance (spa-
tial effects) and seen notably in branched, bulkier precursors. During the hy-
drolysis, inductive effects become important. This is result of both hydrolysis 
(substitution of –OH or –OR) and condensation (substitution of –OSi for –OR 
or –OH) decreasing the electron density of silicon, which in turn increases the 
stability of negatively-charged transition states. This means that in acidic con-
ditions the hydrolysis rate will decrease with each subsequent hydrolysis and 
condensation step but increase under basic conditions due to the enhanced 
electron-withdrawing capabilities of –OH compared to –OR groups. 
According to the illustration in Figure 3, the overall reaction proceeds as 
a poly-condensation to form soluble, higher molecular weight polysilicates. 
This colloidal dispersion is the sol. The polysilicates can link together to form 
a three-dimensional network filled with solvent molecules and spanning the 
container, called the gel or precipitate, as silica. Sol-gel polymerization pro-
ceeds in several possibly overlapping steps, which are monomer polymeriza-
Hydrolysis
(eq. 1)
Esterification
Alcohol condensation
(eq. 2)
Alcolysis
Water condensation
(eq. 3)
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tion to form primary particles, growth of the particles, and the aggregation. 
Sol-gel reaction is highly dependent on the reaction conditions including pH, 
temperature, concentration, and co-solvent. However, hydrolysis and conden-
sation reactions depend most strongly on the nature and the concentration of 
the catalysts, resulting in strong pH dependence. 
Based on the difference in the polymerization process related to the prevail-
ing pH, three pH domains can be separated, pH < 2, pH = 2–7, and pH >7. The 
value pH 2 corresponds approximately to the isoelectric point of silica, IEP 
(electrical mobility of silica particles here equals to zero) and the point of zero 
charge, PZC (surface charge here is zero). Below pH 2 the silicate species are 
positively charged. At pH values < 2 the solubility of silica is relatively low and 
gel times are long (Figure 4). Here the rate of polymerization is proportional 
to the concentration of [H+] ions. At pH 7 there is a boundary since above this 
value solubility of the silicates increases strongly. Silica species are negatively 
charged and hereby stabilized leading preferentially to the growth of large par-
ticles instead of aggregation to a gel.14
The effect of pH is critical. In a basic solution where most of the nanopar-
ticle synthesis occurs, the hydrolysis rate of TEOS increases with the increase 
of pH, while the condensation rate of TEOS is not monotonic. The highest 
condensation rate is around pH 8.4 and decreases when the pH value is below 
or above 8.4. There is no proportional relation between the particle size and the 
applied pH value.
Figure 3. Polymerization behavior of silica. In basic conditions (B) particles grow 
in size with a decrease in number. In acidic conditions (A) or in the presence 
of flocculating salts, particles form aggregates and three-dimensional networks, 
gels.14
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2.1. Synthesis of mesoporous silica through template self-
assembly
Ordered mesoporous silica materials form through the self-assembly process 
of silica species with surfactant structures. During the mesoporous silica syn-
thesis, the prerequisite for mesophase formation is an attractive interaction 
between the head group of structure directing agent and the silica precursor 
through electrostatic, counter-ion mediation or hydrogen-bonding interac-
tions. 
The first four reaction pathways described in Figure 5a–d are of an electro-
static nature. If the synthesis takes place under alkaline conditions and cationic 
quartenary ammonium surfactants are used as the SDA, silicate species are pre-
sent as anions, and the synthesis pathway is termed S+I– (Figure 5a), which is 
the pathway for the M41S-family of materials. When the synthesis takes place 
under acidic conditions (below IEP of Si–OH bearing species, pH≈2) and cati-
onic quaternary ammonium surfactants are used as the SDA, silicate species are 
present as cations and a mediator ion is needed to create interactions between 
those species and the surfactant head group. In this process the synthesis path-
way is termed as S+X–I+ (Figure 5b). If the synthesis takes place under alkaline 
conditions and anionic surfactants (e.g., long-chain alkyl phosphates) are used 
as the SDA, the silicate species are present as anions and a mediator ion is again 
needed. In this latter process the synthesis pathway is termed S–M+I– (Figure 
5c). Conversely, a mediator ion is not required in acidic media, the synthesis 
S–I+ pathway (Figure 5d). 
Figure 4. Solubility of amorphous silica as a function of pH at different 
temperatures.13 
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In the last two reaction pathways presented in Figures 5e–f, the attractive 
interaction between the nonionic SDA (e.g., S0: a long-chained amine; N0: poly-
ethylene oxide) and the silica species are created through hydrogen bonding. 
If silica is present as uncharged silica species, the reaction pathway is termed 
S0I0 (Figure 5e). When silicate is present as ion pairs, the reaction pathway is 
termed S0(XI)0 (Figure 5f).4
Figure 5. Interaction between the surfactant head group and inorganic silica 
enables synthesis of mesoporous material in acidic, basic, or neutral synthetic 
conditions. Electrostatic interactions: S+I–, S+X–I+, S–M+I–, S–I+; through hydrogen 
bonds: S0I0/N0I0, S0(XI)0. (S: surfactant, I: inorganic species, X: mediator ion, 
which is usually a halide).4
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2.2. Alkaline synthesis pathway S+I– is favored to obtain 
monodisperse mesoporous nanoparticles
To attain highly monodisperse particles, a short initial burst of nucleation is fa-
vored, followed by a uniform growth resulting in the synthesis of homogenous 
particles. As stated above, the reaction pathway S+I– (Figure 5a) is the pathway 
for the M41S-family of materials. Alkaline and diluted conditions are typically 
used to synthesize negatively-charged particles to avoid inter-particle aggrega-
tion. 
Generally monodisperse particles are obtained by template-directed alka-
line synthesis and by using very dilute silane concentrations or by the addition 
of particle growth quenchers. The use of a particle growth quencher is interest-
ing as higher product yields can be obtained and higher particle concentrations 
can be reached before aggregation occurs, which leads to more easily scalable 
nanoparticle syntheses. Different mechanisms for synthesis in alkaline condi-
tions related to reaction conditions have been employed, such as dilution to-
gether with pH quenching,17,18 dilute conditions together with water and EtOH 
as co-solvent,6 pH adjustment,19 or mere dilute conditions.20,21 Similarly high 
alkaline conditions with a wide range of reactants have proved to enable par-
ticle size control such as in case of non-ionic polymers or polymers,22–25 fluo-
rocarbon-based cationic surfactants,26 triethanolamine,27,28 and propanetriol,29 
for example. Recently, Yamaha et al. reported a facile size control of MSNs real-
ized by using tetraalkoxysilanes with different alkoxy groups (Si(OR)4; R=Me, 
Et, Pr, and Bu) as silica sources. The average particle size could be controlled in 
the range of 20–80 nm, which can be explained by the different hydrolysis rate 
of the tetraalkoxysilanes (longer alkyl chain leads to lower hydrolysis rate).178 
Experiments have shown that organosilanes together with TEOS in the reac-
tion mixture lead to a smaller particle size compared to using TEOS only as a 
source of silica. These findings indicate that functional silanes can be used as 
size quenchers. The addition of organosilane can, alternatively, affect the nucle-
ation process and lead to a larger number of formed nuclei, i.e. a larger number 
of nuclei are formed and a smaller particle size is obtained.
There are very few mesoporous silica nanoparticle syntheses reported as 
being carried out under acidic conditions, where the nucleation and particle-
growth kinetics is hard to control. However, one of the advantages of acidic 
conditions is the capability of using non-ionic block copolymers as porogens, 
which allows the formation of larger mesopores (>5 nm). Particle size in acidic 
conditions has been controlled by using size quenching with a cationic fluoro-
carbon surfactant26 and by the addition of salts to varying amount of water,30 
for example. 
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2.3. Surfactant packing
The formation of the inorganic-organic mesophase is a co-operative process, 
where all interactions including solvent–silicate, solvent–surfactant, sur-
factant–surfactant, surfactant–inorganics, and inorganics–inorganics are im-
portant. Surfactant packing properties can be estimated based on the critical 
packing parameter (CPP) or surfactant number, which relates the effective 
head group area a0, the critical chain length lmax (normally 80–90% of the fully 
extended hydrocarbon chain) and the volume of the hydrocarbon chains v.
The CPP value gives an approximation of the curvature of the formed liq-
uid crystals, thereby predicting the shape of the micelle. A larger head group 
(Figure 7) in relation to the tail group leads into a higher curvature i.e. to small 
CPP values (<0.5) indicating structures of spherical or rod-like micelles. A high 
CPP value (>0.5) gives an anticipation of flat interfaces such as with flexible and 
planar bilayers having zero curvature. A CPP value of one indicates the forma-
tion of inverse micelles.31 Figure 6 is an illustration of CPPs corresponding to 
surfactant self-assembly during synthesis.32 Although the CPP value gives an 
anticipation of the surfactant self-assembly, experimental conditions such as 
pH, ionic strength and temperature have a strong effect on the hydrophilic– 
lipophilic balance. For instance, the effective head group area a0 can be de-
creased by the presence of an electrolyte, as this leads to a decrease in the elec-
trostatic repulsion by reducing the electrical double layer between the head 
groups. In addition, using pore-swelling agents can control the structure of 
the micelles. A swelling agent such as the widely-used 1,3,5-trimethylbenzene 
(TMB) is a non-polar molecule that is largely located within the hydrophobic 
core of micelles in aqueous solution, thereby increasing the micellar diameter 
and thus the pore size of the final product.33,34
2.4. Methods for template removal
After the silica network has reached a sufficient degree of condensation, the 
templating molecules are no longer needed and can be removed to open the 
porous structure. Since most composite mesoporous materials of this type con-
tain as much as 45–55 wt-% of organic material, the template removal process 
is very important for material preparation.36,37 The template can be removed 
either by calcination or by solvent extraction. Other surfactant removal pro-
cesses include plasma extraction, supercritical fluid extraction,38 and ozone 
treatment.39 
In calcination the as-synthetized dried materials are typically heated in air, 
(eq. 4)CPP = v
lmaxa0
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and by applying heating rates of 1 K/min up to at least 823 K followed by an 
extended period usually 4–8 h of heating at a temperature plateau.36 The heat 
treatment leads to contraction of the silica structure, which is, in turn, a result 
of an increased degree of condensation of the silica network, compared to the 
as-synthetized material.
Figure 6. Critical packing parameters (CPPs) of surfactants with various features 
and their preferred micellar aggregate structures.32
Figure 7. (On the left) Large head groups of surfactants provoke high surface 
curvature, (On the right) while surfactants with large hydrophobic chain volume 
and relatively small head groups creates micellar structure with small surface 
curvature.35
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The template removal by solvent extraction is carried out by different proce-
dures depending on the synthesis employed. For the M41S-family of materials 
prepared under basic conditions via the S+I– pathway, strong electrostatic in-
teractions exist between the cationic surfactant head groups and the negative-
ly-charged silica network. An ion exchange process by using acids or cationic 
proton donors is required to remove the template. Commonly utilized extrac-
tion procedures for materials prepared in basic conditions involve extraction 
in acidic ethanol,40 or an ethanolic solution of ammonium nitrate,37 where the 
removal process can be enhanced by a simultaneous sonication treatment and 
the heating up of the particle dispersion up to 333–343 K during the template 
removal. The thermal treatment can easily lead to decomposition of organic 
functions originating from the co-condensation reactions, and thus ion-ex-
change methods are preferred when co-condensation synthesis is employed.
2.5. Nanoparticle size, surface properties and dispersion 
stability
Important features of nanoparticles aimed at theranostics are their size and 
surface properties, both features influencing the particle dispersion stability 
and the particles’ biopharmaceutical properties. 
Colloidal nanoscale material has high specific surface to volume ratio, i.e. 
high specific surface area per unit of mass (SSA). The measure is important be-
cause many physical and chemical processes take place at the surface of solids. 
As the percentage of atoms at the surface increase and surface interactions be-
come dominant, the properties of materials change. The chemical and physical 
properties of nanomaterials may differ significantly from those of the atomic 
and molecular scale to the bulk materials of the same composition including 
their magnetic, optical, electric, adsorptive, and catalytic properties for exam-
ple.41
Mesoporous silica nanoparticles have a large intraparticular surface that ex-
pands the material total SSA in a remarkable manner compared to that of solid 
nanoparticles. The reactivity of the material increases with the surface area, 
which is high both for nonporous and mesoporous nanoparticles. With respect 
to dispersion this is seen as the material aspiration of a decrease of the surface 
energy by coagulation or aggregation of single particles into larger clusters and 
by nonspecific interaction with molecules in the surrounding media. 
The dispersion properties of silica nanoparticles are determined by the par-
ticle size and by surface properties together with the molecular composition 
of the surrounding media that define the characteristics of the near-surface 
region. Particle-dispersion stability can be achieved by electrostatic or steric 
stabilization and is practically attained by proper particle surface functionali-
zation (Figure 8). As the surrounding media interacts with the surface, a high 
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electrolyte concentration in the physiological environment creates the chal-
lenge of reaching stable particle dispersions via the electrostatic route.42,43
Controlled surface functionalization is not only important for ensuring dis-
persion stability. The theranostic applications of nanoparticles need additional 
functions, where surface chemistry provides means to attach tracing and tar-
geting agents to the nanoparticles.
Figure 8. Surface functionalization can provide dispersion stability electrostatically 
or sterically.44
Figure 9. A schematic illustration of the relative size of nanoparticles and 
biomolecules, drawn to scale.45
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2.6. Surface chemistry of silica
Functional groups of an intrinsic-silica surface consist of silanol and siloxane 
groups. The degree of hydrophilic and hydrophopic properties of the surface 
depends on the amount of hydroxyl, or silanol (Si–OH) and siloxane (Si–O–
Si) groups, covering the surface (Figure 10). The higher the number of silanol 
groups present on the surface the more hydrophilic the silica surface is. The 
protonation and deprotonation of the surface silanol groups determine the sur-
face charge of intrinsic silica nanoparticles and the extent of the repulsive en-
ergy keeping the particles dispersed in a solution.46
Thermal treatment of the material leads to condensation of silanol groups 
(Si–OH) into siloxane (Si–O–Si) bridges. High calcination temperatures (673–
723 K) lead to condensation of unreacted silanol groups after some of the sur-
face groups are lost. Thermal treatment removes water and makes the silica 
network denser and increases its hydrolytic stability in aqueous solutions. The 
constitution of silica-surface groups describes directly the thermal history of 
the material. However, the silica can be re-hydroxylated by boiling calcined 
particles in water (Figure 11),47,52 by acid hydrolysis,48 or by steam treatment.49 
Hydrogen-bonded silanols can be re-activated by thermal treatment, after free 
active silanols are formed.50
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Fig. 2. Types of silanol groups and siloxane bridges on the
surface of amorphous silica, and internal OH groups (see text).
Qn-terminology is used in NMR, where n indicates the number
of bridging bonds (OSi) tied to the central Si atom: Q4,
surface siloxanes; Q3, single silanols; Q2, geminal silanols
(silanediols).
Various problems related to silica surface char-
acteristics are encountered in different areas of
science and technology: physics, chemistry and
physical chemistry, agriculture, soil science, biol-
ogy and medicine, electrical energetics, the oil
processing industry, the metallurgical and mining
industries, some fields of geology, etc. Traditional
building and other materials based on silica, such
as cement, concrete, firebrick, silicate glasses,
rough and fine ceramics, and enamels, occupy a
significant place in human life. Different types of
silica are widely used as efficient adsorbents and
selective absorbents, active phase carriers in catal-
ysis, fillers for polymeric systems, adsorbents and
supports for gas and liquid chromatography,
thickeners for dispersion mediums, binding agents
for molding materials, reinforcing fibres, and so
forth. Chemical modification of the surface of
dispersion silica has received a large amount of
interest; this process allows researchers to regulate
and change adsorption properties and technologi-
cal characteristics of composite materials. Of late
the use of SiO2 is on the rise in the manufacture
of modern high-quality materials (microelectron-
ics, optics, fiber optics, liquid crystals, different
composites including biocomposites, ordered
nanostructured silica materials, monodispersed
colloids, etc.).
In the past 50 years, many reviews have ap-
peared on the subject of surface chemistry of
silica. And we refer readers to these numerous
monographs, reviews, and the most interesting
and significant, in our opinion, articles [1,11–
300].
In view of this, is there need for yet another
review in this field? The author of the present
review article has carried out numerous experi-
mental studies on the subject in question, system-
ized such important characteristics as the
concentration and the distribution of different
types of silanol groups, established the energetic
heterogeneity of the surface in a wide temperature
range of the pretreatment, and investigated the
characteristics of bound water inside SiO2 parti-
cles. Besides, it was made careful study of the
structure characteristics of many different silica
samples. On the basis of these researches the
author was able to construct an original physico-
crease in the adsorption, and the surface acquires
more and more hydrophobic properties [1,36].
Surface OH groups are subdivided as following
(Fig. 2): (i) isolated free (single silanols), SiOH;
(ii) geminal free (geminal silanols or silanediols),
=Si(OH)2; (iii) vicinal, or bridged, or OH groups
bound through the hydrogen bond (H-bonded
single silanols, H-bonded geminals, and their H-
bonded combinations). On the SiO2 surface there
also exist surface siloxane groups or SiOSi
bridges with oxygen atoms on the surface. At last,
there is structurally bound water inside the silica
skeleton and very fine ultramicropores, d1 nm
(d is the pore diameter), i.e. internal silanol
groups.
The last number of decades saw a rapid growth
in those fields of science and technology that deal
with production and utilization of various colloid
and microheterogeneous forms of silica with de-
veloped surfaces, such as sols, gels, and powders.
The properties of a pure silica, as an oxide adsor-
bent, are determined in the first place by: (i) the
chemical activity of the surface — this activity
depends on the concentration and the distribution
of different types of OH groups, and on the
presence of siloxane bridges; and (ii) the porous
structure of the silica.
silica. The obtained products generally have a broad size
distribution.
Crystalline particles exhibit crystal planes at the sur-
face, and the morphology of the crystalline nanoparticles
depends on the crystal class such as cubic, hexagonal,
tetragonal, and orthorhombic (Figure 3 right). For all
nanomaterials, in aqueous environment, the primary
nano-sized silica particles tend to form aggregates.
Porosity
According to IUPAC [28], pores are classified according
to their diameter into micropores (< 2 nm), mesopores
(2-50 nm) and macropores (> 50 nm). Amorphous sol
particles can be microporous or non-porous (dense).
The porosity of Stöber silica can be tuned by adapting
the synthesis parameters: decreasing the ratio of water
to TEOS promotes particle growth by aggregating smal-
ler sub-particles, thus leading to rough particle surfaces
with micropores. In contrast, smooth particle surfac s
are obtained with c nditions of high ratio of water t
TEOS [29]. Silica gel is a powder with particle size in
the micrometer range or larger and is, typically,
mesoporous.
Zeosils and clathrasils have characteristic pores and
cages in the micropore size range, depending on frame-
work topology. Examples of porosil frameworks are
shown in Figure 4 [22].
When the silica is presented as a nanopowder, poros-
ity can be an intrinsic and extrinsic characteristic: sta-
pling of the elementary nanoparticles gives rise to an
interparticle porosity, which often is difficult to distin-
guish from the intrinsic intraparticle porosity, especially
when deali g with esopor sity.
Hydrophilic-hydrophobic properties
The hydrophilicity of a silica material increases with the
number of silanols, or silicon-bonded hydroxyl groups,
capable of forming hydrogen bonds with physical water
molecules. The chemical formula of silica is represented
as SiO2.xH2O, in which water represents chemical water
contained in silan l groups present on the surf ce of the
silica material. These water molecules are not to be con-
fu ed with cryst l water, such as that resent i many
inorganic salt crystals. The urfa e chemistry of silica is
depicted in Figure 5. Vicinal hydroxyl groups (one
hydroxyl group per tetrahedron) located at mutual dis-
tances smaller than 3 nm are engaged in hydrogen
bonding. Geminal hydroxyls (2 hydroxyl groups per tet-
rahedron) are considered to occur in minor concentra-
tions. Isolated silanols are positioned too far apart to be
engaged in hydrogen bonding. Because of the differing
chemistry of these 3 types of silanol groups, they are
not all equivalent in their adsorption behavior or chemi-
cal reactivity. Vicinal hydroxyls interact strongly with
water molecules and are responsible for the excellent
water adsorption properties of silica, which are exploited
in industrial gas drying operations, for example.
The reported concentration of ydroxyl groups per
square nanometer on the surface of amorphous silica
ranges from 4 to 5 OH/nm2 [12]. As compared with
amorphous silica, the crystalline forms of silica generally
contain a lower concentration of surface hydroxyl
groups [15]. Hydrogen-bonded water molecules are
removed when silica is heated at 170°C under atmo-
spheric pressure or at room temperature under vacuum.
Colloidal silica, precipitated silica and ordered meso-
porous silica and silica gel are hydrophilic because of
their high concentration of silanols. Silicagel, for exam-
ple, can adsorb water in quantities up to 100% of its
proper weight.
Porosils typically are hydrophobic because they lack
silanols in the pores of their framework. Silica produced
at high temperature, such as pyrogenic and vitreous
Figure 4 Atomic representation of (left) a zeosil with
microporous channels (MFI type) and (right) clathrasil with a
denser framework (SOD type). Black and gray circles represent
silicon and oxygen atoms, respectively. Figure made with Vesta 2.0.3
[178] with unit cell coordinates from [22].
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Figure 10. Presented (On the left) are various types of silanol groups and siloxane 
br dges on the surface of amorph us silica, as well as intern  sila ol groups.51 (On 
the right) the hydrophobicity versus hydrophilicity of the particles is determined 
by the proportion of various surface groups on the particle surface. 50
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2.7. Functionalization of the silica surface
The possibilities for functionalization of the silica surface are many and often 
based on the use of functional silanes. The composition of the particle surface 
determines its interaction with the surrounding media, which in turn has a 
high impact on the particle-dispersion stability. Tracing and targeting moie-
ties can be conjugated on the particle surface to introduce theranostic features 
such as those facilitating their specific interaction with cells. The overall com-
position of the silica surface has a high impact on the pharmacokinetics of the 
particles in a biological environment. 
Mesoporous silica nanoparticles have three topologically distinct regions 
that can be independently functionalized -the silica framework, nanochannels 
or pores, and particle exterior. Functional groups of the external surface are 
more accessible and therefore predominantly functionalized as compared to 
intraparticular surface groups. To selectively functionalize the outer surface 
the template removal can be accomplished after the functionalization. Selec-
tive functionalization of the intraparticular surface can be done for example by 
first passivating the outer functional groups, then by functionalizing the inner 
surface and finally by removing the groups used for passivation (Figure 16).53
The functionalization of inorganic silica through organic moieties combines 
the advantages of organic functionalities with an inorganic substrate to create 
hybrid materials. The silica framework provides structural order as well as ther-
mal and mechanical stability while organic species permit versatile control of 
interfacial and bulk material characteristics such as porosity (e.g. gate-keeping 
polymers), hydrophobicity, and optical (e.g. fluorophores),54–56 electrical (e.g. 
conducting polymers),57–59 or magnetic properties (e.g. organic chelates that al-
low forming of complexes with magnetic resonance imaging (MRI) contrast 
agents).60,61 Surface functionalization of silica can be carried out by using vari-
ous methods including covalent binding, chemisorption, electrostatic or hy-
drophobic interaction. The covalent conjugation is the most stable and selec-
tive, and in this study the focus is on covalent functionalization only.
Figure 11. Rehydroxylation of the silica surface by boiling the particles in water 
can be utilized to create active free silanol groups reactive for further surface 
functionalization.52
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Functionalization of amorphous silica can be accomplished by co-conden-
sation, by post-synthetic grafting “silanization”, or by surface polymerization 
that includes “grafting to” or “grafting from” methods.4,62–64 Functionalization 
means can also be combined relatively freely, enabling the flexible design of 
theranostic agents.
2.7.1. Direct functionalization by co-condensation
Co-condensation of tetraalkoxysilanes [(RO)4Si (TEOS or TMOS)] with ter-
minal trialkoxyorganosilanes of the type (R’O)3SiR forms Si–C bonds. The ap-
proach enables incorporation of a variety of organic groups into the material 
during the one-pot sol-gel synthesis where organic residues are anchored di-
rectly to all particle surfaces (Figure 12).4 Furthermore, this method enables the 
preparation of imageable particles in one step. In practice this is conducted by 
pre-reacting fluorophore with organosilane (Figure 13), which is subsequently 
used in the co-condensation synthesis, yielding inherently fluorescent silica 
nanoparticles. For instance, isothiocyanate group consisting fluorophores, e.g. 
fluorescein isothiocyanate (FITC) or tetramethylrhodamine-5-(and 6)-iso-
thiocyanate (TRITC) can be conjugated with an organosilane primary amino 
groups and hereby be incorporated directly into the particle network.15
Since the organic functionalities are introduced during the synthesis stage, 
pore blocking is not a problem. The organic units are generally more homoge-
neously distributed in the material compared to material functionalized by a 
grafting process. However, an increased concentration of organic groups in the 
network can lead to a decreased degree of mesoscopic order, and a reduction 
in the pore diameter, pore volume, and specific surface areas. As the co-con-
densation synthesis includes structurally different precursors having different 
hydrolysis and condensation rates, there is a change in the tendency of homo-
condensation reactions and nonhomogenenous distribution of organic func-
tionalities in the framework. Furthermore, as the organic groups are already in-
Figure 12. Co-condensation “direct synthesis” method can be employed to modify 
mesoporous silica phases with organic groups. R = organic functional group. It 
is worth to note that, in contrast to the illustration, the surface consists of both 
organic groups and silanol groups.53
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corporated into the material during the synthesis, the extraction method must 
be sensitive so as not to destroy the organic functionality during removal of the 
surfactant. Commonly only extractive methods can be used.4
2.7.2. Postsynthetic functionalization of silica by grafting
In the grafting method “silylation” the surface silanols serve as anchoring 
groups where both free (≡Si–OH) and geminal silanols (=Si(OH)2) are re-
sponsible for active silylation, while hydrogen-bonded silanol groups are less 
accessible. The conjugation of surface silanols and organosilanes progresses 
through simple elimination reactions.50 The silanization is often carried out in 
organic solvents, but the importance of trace water is pointed out in several 
reports.65 The influence of physisorbed water has been emphasized especially in 
surface modification of aminoalkoxysilanes,66–68 while some reports state that 
the silanization reaction with aminopropylsilanes is self-catalyzed and siloxane 
bonds are formed also in the absence of water.69,70 
The grafting approach for silica was demonstrated already in 1992 by re-
searchers from Mobil Oil where the MCM-41 surface was modified by tri-
methylsilyl groups.71 The procedure is carried out primarily by reaction of 
organosilanes of the type (R’O)3SiR, or less frequently chlorosilanes ClSiR3 or 
silazanes HN(SiR3)3. Functionalization with a variety of organic groups can 
be realized by variation of the organic residue R. Most of the commonly-used 
organosilanes such as 3-aminopropyltriethoxysilane (APTS) and 3-aminopro-
pyltrimethoxysilane (APTMS) have one organic substituent and three hydro-
lysable substituents in their molecular structure (Figure 14).15 In the post-syn-
thetic grafting approach the material is synthesized without disturbance of the 
organosilanes yielding therefore hydrothermally more stable “compact” mate-
562
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A silane compound is a monomeric silicon-based molecule containing four constituents. Since 
silicon is in the same family as carbon on the periodic table, it too is able to form covalent bonds 
with four other atoms. H owever, it is less electronegative than carbon and undergoes reac-
tions that are unique compared to typical organic compounds. Silanes that contain at least one 
bonded carbon atom are called organosilanes. O rganosilanes also can have hydrogen, oxygen, 
or halogen atoms directly attached to the silicon atom core. Some of these derivatives are highly 
reactive and can be used to form covalent linkages with other molecules or surfaces. T he more 
useful organosilanes are those that contain a functional organic component in addition to one 
or more silane reactive groups. T he organic portion also may contain a reactive group, which 
allows conjugation of the organosilane molecule to other organic compounds. C onversely, the 
silane reactive groups typically are unreactive toward organic molecules, but can covalently cou-
ple to certain inorganic substrates. T he advantage of this type of functional silane derivative is to 
promote the bonding of an organic molecule to an inorganic particle, surface, or substrate. 
T he general structure of a functional silane coupling agent is shown in Figure 13.1 . T he 
organic arm typically has a structure that terminates in a functional group or reactive com-
ponent, which facilitates the covalent linkage to another organic molecule. T he other part 
 Silane Coupling Agents 
Figure 13.1  T he general structure of a silane coupling agent includes a functional group or reactive group at 
the end of an organic spacer. T his alkyl chain is attached to the central silicon atom, which also has up to three 
hydrolysable groups attached to it.  
Figure 13. General structure of an organosilane.15
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rial compared to that synthesized via co-condensation approach (Figure 15). 
However, the grafting method often leads to a heterogeneous surface coverage, 
where grafting occurs with higher efficiency in pore openings and in a low-
er quantity on the intraparticular surface.72 The functionalization conditions 
such as the polarity and dielectric constants of solvents have been reported to 
strongly affect the concentration of grafted organic groups and the degree of 
their site-isolation.72,73 Here, the site-isolation of organic groups is considered 
to be their sites or locus separated by a sufficient distance to prevent the hy-
drogen bonding between adjacent groups such as amines, which makes them 
reactive for further functionalization.
Figure 14. Molecular structures of widely used terminal trialkoxyorganosilanes 
APTS and APTMS.15
Figure 15. A schematic illustration of co-condensation (on the left) and grafting 
(on the right).4
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2.7.3. Surface polymerization
Polymer coating alters the interfacial properties of the particles. Surface po-
lymerization can be used to increase the number of outer functional groups, 
or “anchoring groups”, to increase particle-suspension stability by providing 
electrostatically- or sterically-stabilized particle suspensions, or “smart gate-
keeper” polymer surfaces, capable of responding to external stimuli such as 
temperature, pH, or ionic strength.74–77 The gate property responds to an exter-
nal trigger to release the cargo such as drug molecules or imaging agents from 
the voids of mesoporous particles. 
Although polymer adsorption onto a surface is a widely-used means of 
surface functionalization, in this study only covalent surface polymerization 
was employed. Covalent grafting involves either “grafting to” or “grafting from” 
methods. “Grafting to” is maintained through conjugation of reactive macro-
Figure 16. An illustration of selective grafting on external and internal surfaces of 
mesoporous silica material.53
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molecules with compatible surface groups. This technique has limitations and 
can lead to low grafting densities due to steric crowding of reactive sites by 
previously attached polymers.78,79 The “grafting from” method allows a higher 
control of functionality, density, and thickness of the polymer brushes.80,81 A 
higher grafting density can be achieved by using small monomers not suffer-
ing from steric hindrance and having access to the active initiation sites.74 A 
surface-initiated “grafting-from” technique is versatile and allows creation of 
polymer chains of a “dendritic nature”, which increases the number of outmost 
functional groups available for further modification.75,76
The hyperbranching ring-opening polymerization of aziridine initiated by 
silanol groups forms hyperbranched polyethyleneimine-modified particle sur-
faces leading to highly positively charged particles with increased electrostatic 
stability in physiological conditions (Figure 17).63,76,78 Polyamino functionalized 
surfaces have also shown to be capable of creating pH controlled gate “open-
close” systems, advantageous for smart drug delivery systems (Figure 18). 
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contained within the interface was to first form an imine of surface-bound
amines with 4-nitrobenzaldehyde using a surface with known surface area.
The surface-bound imine was then separated from excess soluble benzalde-
hyde and then hydrolyzed to generate a solution of the aldehyde that was
analyzed by UV-visible spectroscopy [75]. A starting surface that had been
functionalized with (3-aminopropyl)diethoxymethylsilane was shown to have
3.5 amines/nm2 and a film thickness of 8 A˚. After a typical reaction with
aziridine, the film thickness increased to 36 A˚. By assaying the change in
surface density of primary amines with time, it was possible to show that
this grafting was producing a hyperbranched polymeric graft. The surface
density of primary amines was measured to be 66 amines/nm2 after reac-
tion of the amine-functionalized surface with aziridine for 24 h. This cor-
responds to a very dense graft with a concentration of 18 amines/nm3.
The maximum concentration of total amines for polyethyleneimine assum-
ing that polyethyleneimine has a density of 1 g/cm3 would be ca. 14 amine
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Figure 17. Hyperbranced surface polymerization. Surface grown polyethylene 
imine (on the left) grown from amino groups (on the right) grown from silanol 
groups.15
Figure 18. pH responsive molecular gate created by polyamines. The gate “open-
close” mechanism is based on hydrogen-bonding interactions between amines 
(open-gate) and Coulombic repulsion between ammonium groups (closed-gate).77
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Another commonly used polymer for silica surface functionalization is 
polyethyleneglycol (PEG). It has been been widely used for creation of steri-
cally stabilized nanoparticles. Rapid nanoparticle clearance from the body is 
maintained by the body defense system (reticulo-endothelial system, RES) that 
recognizes an object as foreign. Anchoring of PEG on the nanoparticle surface 
has been reported to significantly decrease the RES uptake by reorienting it to-
wards the aqueous solution, creating steric stabilization and preventing protein 
adsorption on the particle surface (i.e. opsonization).81 There are a wide num-
ber of functional PEGs commercially available. The “grafting to” method can 
be utilized to conjugate PEG polymers to the particle surface. Grafting-from 
synthesis of PEG, grown directly from silica surface via anionic ring opening 
polymerization of glycidol by using Si–OH groups as the initiators, has also 
been reported.75
Versatile external stimuli responsive polymer surfaces acting as valves to 
open and close the mesopores in a reversible manner have been reported. 
An example of a widely used thermoresponsive polymer is poly(N-isopropy-
lacrylamide) (PNIPAM). Furthermore, the polymer technology allows the use 
of co-blockpolymer type of moieties consisting of, for example, an external 
stimuli reactive block and a stealth polymer outer block. Here, the aim of the 
external stimuli block is to close the pores, while the aim of the stealth block on 
the outer particle surface could provide the colloidal stability.78
2.8. Standard bioconjugation strategies
To target nanoparticles in an effective manner, bioactive ligands can be conju-
gated to the outer surface of the particles. Bioconjugation can be employed to 
modify surfaces initially derived from co-condensation, grafting or surface po-
lymerization to be further coupled with spacer arms or cross-linkers to create 
reactive groups for coupling small molecular ligands or biomolecules.
In this chapter the most common conjugation techniques are introduced. 
For complete report of all available techniques Bioconjugation techniques and 
Recent Advances of Bioconjugation Chemistry in Molecular Imaging are re-
ferred.15,82 Here, the most common conjugation techniques are separated into 
three broad categories, which are zero-length cross-linking, cross-linker medi-
ated linking, and conjugation through streptavidin–biotin interaction.
For a nanoparticle functional group–biomolecule functional group pair 
there are usually several coupling methods available, with the choice of method 
based on the effectiveness, particle stability, and bioactivity loss associated.
2.8.1. Zero-length cross-linkers
Zero-length cross-linkers form chemical bonds between functional groups 
of the molecule to be conjugated and the particle surface functional groups, 
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without the use of a mediating linker. 
A popular method for covalent linking of biological functions by using 
zero-length cross-linkers is the use of 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide hydrochloride (EDC)-mediated carboxyl-amine coupling to form 
an amide “peptide” bond. Bioconjugation by amide bonds is very common 
since biomacromolecules such as antibodies usually possess several primary 
amino and carboxylic acid groups. EDC is a water-soluble derivative of N,N’-
dicyclohexylcarbodiimide (DCC). These compounds convert carboxylate into 
an O-acylisourea intermediate. However, this intermediate is unstable in water 
leading to deactivation of the molecule via hydrolysis. Due to this N-hydrox-
ysuccinimide (NHS), or its more water-soluble derivative N-hydroxysulfos-
uccinimide (sulfo-NHS), is used in combination with EDC, in order to ob-
tain more stable NHS–ester intermediates to retain coupling capacity in water 
(Figure 19). Many compounds are commercially available in their preactivated 
NHS-ester-form, and the compounds can be stored in a solid state or an anhy-
drous solution. 15,83
2.8.2. Cross-linkers
The chemical composition of nanoparticles and the molecules that are to be 
linked to the nanoparticle surface are not necessarily sufficient for a direct con-
jugation. In these cases, a cross-linker that is composed of a spacer with two 
terminal chemical groups that bind complementary groups on the nanoparticle 
and the biomolecule can be used. One example of a homobifunctional cross-
linker is O,O’-Bis[2-(N-Succinimidyl-succinylamino)ethyl]polyethylene glycol 
consisting of an active NHS group at each end, capable of linking two amine 
groups together (Figure 20). Generally, a cross-linker containing two similar 
functional groups is called homobifunctional and a cross-linker with two dif-
ferent functional groups is of a heterobifunctional character.
In the reaction scheme shown in Figure 21, amine groups are coupled with 
thiol groups by applying a cross-linker with NHS ester and maleimide groups 
on opposing ends. In this example sulfo-succinimidyl-(4-N-maleimidomethyl) 
cyclohexane-1-carboxylate (sulfo-SMCC) is employed.86,87
Figure 19. The carboxyl group activation reaction induced by EDC and sulfo-
NHS to form stable amide bonds.84
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Figure 20. The chemical structure of a homobifunctional PEG O,O’-Bis[2-(N-
Succinimidyl-succinylamino)ethyl]polyethylene glycol with activated carboxyl 
groups “NHS esters” at both ends capable of forming bonds with primary amino 
groups.85
Figure 21. The sulfo-SMCC cross-linker is capable of forming maleimide-activated 
moieties which can further form covalent bonds with sulfhydryl (-SH) functional 
groups.14
amines can be monitored by an amine detection reagent such as trinitrobenzene sulfonic acid 
(T N BS; C hapter 1, Section 4.3). T he procedure forms the basis for a highly sensitive assay for 
protease activity. 
Succinylated derivatives of nucleic acids may be prepared by reaction of the anhydride with 
available O H  groups. T he reaction forms relatively stable ester derivatives that create car-
boxylates on the nucleotide for further conjugation or modifi cation ( Figure 1.83 ).  T his method 
has been used in nucleic acid synthesis (M atteucci and C aruthers, 1980) and to derivatize 
nucleotide analogs such as A Z T  (T adayoni  et al . ,  1993). 
Succinic anhydride also is a convenient extender for creating spacer arms on chromatogra-
phy supports. Supports derivatized with amine-terminal spacers may be succinylated to totally 
block the amine functionalities and form terminal carboxylic acid linkers for coupling amine-
containing affi nity ligands (C uatrecasas, 1970). 
104 1. Functional Targets
Figure 1.81  Succinic anhydride reacts with primary amine groups in a ring-opening process, creating an amide 
bond and forming a terminal carboxylate.  
Figure 1.82  T he hydroxyl group of serine residues and the phenolate ring of tyrosine groups may be modifi ed 
with succinic anhydride to produce relatively unstable ester bonds. In aqueous conditions these reactions are 
minor due to competing hydrolysis by water. 
Figure 22. Carboxylation of amino surfaces by a ring-opening reaction of succinic 
anhydride.15
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Another widely used cross-linker is succinic anhydride operating through a 
ring opening reaction with primary amine groups and thus converting them to 
carboxylate groups. Carboxylate groups can further be linked through activa-
tion with an amine group for example (Figure 22).
For targeted delivery, i.e. the specific interaction of the particle system with 
a target site, the targeting moieties (small molecules, or biomolecules such as 
proteins or peptides, antibodies or oligonucleotide or viral proteins) must be 
accessible on the outer particle surface in order to enable cell-specific recogni-
tion. It is worth noting that a short linker gives less spatial freedom for the tar-
geting molecule to bind with its target molecule compared to a longer spacer.
2.8.3. Streptavidin–biotin interaction
Highly specific particle–biomolecule conjugates can also be formed through 
protein-ligand interactions. The most popular protein-ligand linking chemistry 
is the non-covalent interaction between streptavidin and biotin. Streptavidin 
consists of four identical streptavidin monomers, and therefore the molecule 
has four biotin binding sites. Streptavidin–biotin complex has an association 
constant in magnitude of 1015, the highest known in biochemistry. The high as-
sociation constant originates from a high shape complementarity between the 
binding pocket and biotin and from an extensive hydrogen bond network be-
tween the molecules. Streptavidin-biotin complex (Figure 23) is stable within 
a wide range of pH conditions and up to high temperatures. It is well known 
that ligand binding gives an increment in the thermal stability of a protein. 88,89
Figure 23. X-ray crystal structure of tetrameric streptavidin bound with four 
biotin molecules.90
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3. Nanoparticles for molecular imaging
Molecular imaging was first developed to localize antigens in light microscopy. 
Nanotechnology has now enabled molecular imaging to encompass all imaging 
modalities. To obtain good image quality, accumulation of contrast agents in 
the target site is a prerequisite and can be carried out by employing targetable 
imaging agent-containing nanoparticles to the site of action. Silica nanoparti-
cles have been synthesized with wide range of contrast agents to enable their 
use in diverse imaging techniques. They have been coupled with fluorescent 
and entities for optical imaging,91–95 with radionucleotides for positron emis-
sion tomography (PET)96,97 and with various contrast agents for increase the 
contrast in magnetic resonance imaging (MRI).95,98 In this study, fluorescent-
ly-labeled silica nanoparticles were traced in the bioenvironment by optical 
imaging. 
3.1. Fluorescently-labeled silica nanoparticles
Conventional molecular imaging employs labeled proteins such as monoclonal 
antibodies as imaging probes. However, the chemical modification of proteins 
is limited due to the potential loss of their biological functionality. The limit is 
approximately ten substitutions per molecule after which the antibody loses 
its antigen-recognition capability. Compared to this, the loading capacity of 
imaging agents in one single nanoparticle is remarkably higher, and beneficial 
especially for imaging modalities that are low in sensitivity. Conjugating them 
to nanoparticles provide a way for significant signal amplification. Particularly 
often the imaging and targeting is combined, as the contrast agents are incor-
porated into the carrier matrix while the particle surface remains free for sub-
sequent conjugation of targeting moieties.99–101
The well-studied functionalization techniques, co-condensation or graft-
ing, can be used to synthesize fluorescently labeled silica nanoparticles. Fluo-
rophores are trapped inside the inorganic material that protects them from the 
external environment, which reduces significantly the chemical or biological 
quenching. The high intensity and excellent optical stability of fluorescent na-
noparticles enables ultrasensitive analytic determination, selective recognition, 
sensitive imaging and reporting and the monitoring of rare biological events 
that are otherwise undetectable using existing fluorescence-labeling tech-
niques.102 
High numbers of fluorescent probes are available in their functionalized de-
rivatives. Fluorescein (Ex/Em 494/518 nm) and its derivatives represent one of 
the most popular fluorescent-labeling agents. The fluorescent character of the 
fluorescein molecule originates from the presence of a fused three-ring aro-
matic structure. Most of its derivatives are prepared through substitutions to 
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carbons 5 and 6. Generally the functionalization of the fluorophore does not 
have any major impact on the fluorescent properties (Figure 24).15
Fluorescent probes can be covalently conjugated inside the silica network 
by replacing small amounts of alkoxysilane with an organosilane. For instance, 
aminosilane can react with several fluorescein derivatives such as fluorescein 
isothiocyanate (Figure 25) or fluorescein N-hydroxysuccinimide (NHS) (Fig-
ure 26). Grafting fluorophores to functional groups of the nanoparticle is the 
post-synthetic way of preparing fluorescent silica nanoparticles. Another ben-
efit of nanoparticle technology is the option to multilabel the particle, for in-
stance the particle structure-wise, and in this way to track several parameters 
simultaneously. 
The type of label used and the labeling strategy must be considered carefully. 
Dyes have different quantum yields and therefore the amount of fluorophore 
needed varies depending on the label used. Some of the dyes are highly sen-
sitive for pH changes.103 Furthermore, multilabeling and the use of too high 
concentration of one and same fluorophore can lead to self-quenching. For in 
vivo imaging, near infrared (NIR)-emitting fluorophores are advantageous as 
their spectral window is between 650 and 1000 nm, which is the wavelengths 
that have minimum interference from tissue auto-fluorescence and can trans-
mit tissues to be monitored outside the animal.104
Figure 24. Molecular structure of fluorescein (on the left) and fluorescein 
isothiocyanate (on the right).15
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Figure 25. Fluorescein isothiocyanate can react with primary amines such 
as aminosilanes to form a stable covalent thiourea bond. By utilizing the co-
condensation approach, the contrast agents can be taken to the silica material 
structure during the synthesis step.15
Figure 26. NHS-Fluorescein (5-carboxyfluorescein succinimidyl ester) reacts with 
primary amine groups to form an amide bond.15
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4. Receptor-mediated uptake of nanoparticles
4.1. Active targeting
In order to actively target specific cells, the external surface of the silica particle 
can be modified with chemical entities acting as ligands for cell membrane re-
ceptors. Active targeting provides benefits over traditional treatments through 
increased efficacy as therapeutic agents are targeted specifically to the site of 
action while minimizing off-target side effects caused by the dosing of normal 
tissues. Targeting agents are classified in proteins (mainly antibodies and their 
fragments), nucleic acids (aptamers) or other small receptor ligands (peptides, 
vitamins, hormones, and carbohydrates).91 Passive targeting of nanocarriers is 
a mechanism of tumor biology during which particles accumulate in the tu-
mor site through the enhanced permeability and retention (EPR) effect. Silica 
nanoparticles have been successfully targeted using peptides, proteins105,106 and 
small molecules as targeting ligands.107,108
The targeting of nanoparticles occurs via cell-surface protein recognition 
and following particle binding to that receptor. Next, depending on the surface 
protein character, particles are either internalized to cells via specific endocy-
tosis mechanisms or they remain attached to the cell surface receptor. Endo-
cytosis is an active transport process dependent on time, pH, temperature and 
energy.109 The four basic endocytosis mechanisms are caveloae- and chlath-
rin- mediated endocytosis, macropinocytosis, and chlathrin- and caveloae-
independent endocytosis.110,111 It is challenging to draw general conclusions 
about how to produce particles for optimal cellular uptake, as the rate and the 
mechanism of uptake are cell-type dependent and vary between nanoparticles 
of different sizes, charges, and other surface properties. 
Because particles with a positive charge address an attractive force towards 
a negatively-charged cell surface, one would anticipate that positively-charged 
particles would be endocytosed more efficiently than negatively charged par-
ticles. The work of Harush-Frenkel et al. indicated that this was true for HeLa 
cells. The positively-charged nanoparticles with a diameter of 80 nm had an 
uptake 2-fold higher than that of negatively charged particles of an equal size.81 
Slowing et al. obtained similar results. They studied internalization of 150 nm 
mesoporous nanoparticles functionalized with 3-aminopropyl (AP), N-(2-
aminoethyl)-3-aminopropyl (AEAP), N-folate-3-aminopropyl (FAP) and 
3-[N-(2-guanidinoethyl) guanidino]propyl groups and particles with intrinsic 
silanol groups. Particle internalization in HeLa cells was purely dependent on 
the surface charge with highly charged particles uptaken at a faster rate.112 In 
contrast to these results, a higher uptake for negatively-charged particles had 
been observed in HEK cells, reported by Zhang et al.113 Maneerat et al. studied 
the effect of size and surface charge. They prepared mesoporous particles with 
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sizes of 10 nm and 50 nm. Uptake studies were conducted in ovarian cell lines 
for particles with intrinsic silanol, amino, and carboxyl groups. The results in-
dicated that intrinsic 10 nm particles and 50 nm carboxyl-modified particles 
had the highest uptake in each particle size class.114 These studies show that 
more research on the topic is needed to clearly understand all related factors. 
For instance, the polyvalent surface of nanoparticles may induce cross-linking 
of cellular receptors, start signaling processes and induce structural alterations 
on the cell surface, and interfere with normal cell functions.115,116
Moreover, there may be cell-type-specific differences in the handling of 
already internalized particles such as in intracellular sorting, trafficking, and 
particle localization.115 The cellular uptake of nanoparticles is also shown to 
be concentration- and time-dependent. Longer incubation times and higher 
concentrations have been shown to enhance the uptake of particles conjugated 
with a targeting ligand and control particles.102,117 
To reach high cell selectivity, a surface marker should be overexpressed on 
target cells, where receptor density of 104–105 copies per cell is reported to be 
the limit for effective cell recognition. It is generally known that multivalent 
binding of an object with its target cell leads to a higher binding affinity, which 
increases the targeting efficacy. It is, therefore beneficial to aim for a higher 
ligand density on the nanocarrier surface. Dendrimer nanocarriers conjugated 
with 3–15 folate molecules were reported to have 2500–170 000 -fold higher 
dissociation constants (KD) over free folate when comparing the binding ef-
ficiency to the folate-binding proteins immobilized on an artificial surface.118
4.1.1. Antibodies as targeting ligands
Antibodies or immunoglobulins (Ig) are a group of proteins that are found in 
the blood serum and tissue fluids of mammals. Their role in the adaptive im-
mune system is crucial because they recognize and bind to foreign compounds 
(antigens) and trigger the elimination of those compounds by creating a spe-
cific reaction to each infectious compound and eradicates that from the body. 
The key features of the adaptive immune system are its specificity and memory. 
The system remembers infectious compounds and can prevent it causing dis-
ease later.119
There are five classes of Igs: IgG, IgA, IgM, IgD and IgE. The major Ig class is 
of the igG-type, accounting 70–75% of the total Ig content of serum. The aver-
age molecular size of IgG is approximately 150 kDa. The molecule is composed 
of four peptide chains, two identical heavy chains with an average size of 50 
kDa and two identical light chains of about 25 kDa, thus forming a tetrameric 
quaternary structure. The two heavy chains are linked to each other with a light 
chain of disulfide bonds (Figure 27).119
Targeting cancer with monoclonal antibodies (mAb’s) was first demonstrat-
ed by Millsten in 1981.120 It is possible to create a monoclonal antibody specific 
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to almost any extracellular cell-surface target, which makes mAb’s an attractive 
class of targeting ligands for nanocarriers. There are already thousands of iden-
tified markers on tumor cells, for which there is a “matching” monoclonal an-
tibody pair available.121 MAb’s have been used for targeting nanoparticles both 
in vitro and in vivo. 
As the antibody molecules are relatively large, single-chain fragment vari-
able recombinant antibodies (scFv) with an average size of 25kDa have been 
synthetized by genetic engineering.122 Antibody fragments have an improved 
biodistribution compared to that of intact IgGs due to their small size and ab-
sence of the highly immunogenic molecular stem. However, these molecules 
have proved to have a shorter retention time and express a decreased affinity 
and specificity compared to those of antibodies.117 
Several studies have demonstrated the antibody-targeted silica in vitro and 
in vivo.126,127 Tsai et al. successfully targeted breast cancer cells by using Her-
neu mAb conjugated mesoporous silica particles.105 The conjugation of bio-
molecules to an inorganic robust matrix such as nanoparticle surface generally 
Figure 27. (On the left) A schematic illustration of an IgG type antibody. An IgG 
has two light and two heavy polypeptide chains. The Fab “antigen-binding region” 
consists of the light chains. The Fc region is the antibody stem, which is composed 
of the two heavy chains. The chains are bound together with covalent disulfide 
bonds and noncovalent interactions. The Fc part of the molecule is responsible of 
the immunogenicity. (On the right) an x-ray crystallographic structure of an IgG 
molecule.119 
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increases the stability of the biomolecule,128 similar to a noncovalent interac-
tion, such as a substrate ligand interaction that stabilizes the protein’s three di-
mensional structure. Increased stability extends the lifetime of the biomolecule 
in various bioenvironments. As high numbers of ligands can be conjugated to 
one single particle, the multiple binding of ligands to their target cells is used 
to facilitate recognition and to increase binding efficacy.119 Mazzuccelli et al. 
reported a successful targeting of silica nanospheres to HER-2 overexpressing 
breast cancer cells by using anti-HER-2 scFv fragments as targeting ligands. 
These single-chain fragments exhibit a decreased retention time, decreased af-
finity as well as decreased specificity compared to those of intact HER-2 anti-
bodies. By conjugating of multiple fragments to the silica nanoparticle surface, 
the binding efficacy was increased 4-fold, which is close to the affinity of intact 
anti-HER-2.117 
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5. Drug incorporation and release
The drug loading of mesoporous silica nanoparticles is typically a postsynthet-
ic procedure. Drugs can be incorporated into the nanocarriers by surface ad-
sorption or by covalent conjugation.129,130 MSN’s possess high specific particle 
surface and large pore volumes, allowing incorporation of large quantities of 
drugs.131
The drug cargo can be incorporated inside the nanocarrier while guiding 
ligands are located on the surface to accomplish the task of targeted drug de-
livery. The targeting ligand can also function as a therapeutic drug.107 Drug 
incorporation into nanocarriers allows the use of drugs with low hydrolytic 
solubility and stability, providing opportunity for reappraisal of drugs previ-
ously ignored because of their poor pharmacokinetics.132 The ceramic matrix 
of the silica carrier remains intact in organic solvents, which enables different 
types of solvents to be used in the drug loading steps. The solvent can be chosen 
in terms of drug’s solubility in order to facilitate the drug adsorption to the pore 
walls over solvent-drug interactions. Because the drug incorporation process 
can be conducted in organic solvents, the repulsive forces between the carrier 
surface and the drug molecule that might be an issue in aqueous conditions 
due to electrostatic interactions (charges) and pH dependencies, in addition 
to possible drug hydrophobicity, can be discounted. On the other hand, when 
the drug is more hydrophilic, aqueous solutions and pH matching can be used 
to optimize the drug adsorption.16 In most cases, even after the functionaliza-
tion process, the vast majority of the groups present on the silica surface are 
still silanol groups. Therefore the influence of the silanol groups on the overall 
chemistry of the pore surface should not be underestimated.133 Drug adsorp-
tion to the carrier matrix leads typically to a monolayer formation and can be 
modeled using a Langmuir adsorption isotherm.134 Monolayer adsorption onto 
the pore walls has also been observed for proteins from aqueous solutions.135 To 
avoid premature drug release, the drug can be covalently linked to functional 
groups present on the pore wall.107,130,136 Depending on the physico-chemical 
properties of the drug, the drug loading inside the nanocarrier can provide the 
means for sustained release in order to maintain a drug concentration within 
a therapeutic window. One way to adjust the release profile is using molecu-
lar gates attached to the pore entrances or inside the pores themselves, which 
can be triggered by an external stimulus.137 Other factors affecting the release 
profile are the particle pore size and particle matrix degradation. Moreover, 
the physical state that the incorporated drugs holds -amorphous, crystal or a 
combination- has an influence on the drug dissolution rate. 
Biodegradable mesoporous silica nanoparticles have widely been reported 
as novel drug delivery systems holding promise especially in cancer thera-
py.137–139 The porous matrix may protect biomolecules from enzymatic deg-
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radation. Silica nanoparticles have also been successfully used as carriers for 
targeted delivery of proteins, such as insulin, HIV-gp120, and Cytochrome 
C.117,140–142 Another very interesting therapeutic approach is the controlled de-
livery of vaccines. Antisense nucleotides usually have poor stability and cannot 
easily penetrate cells, and thus loading the compounds into a carrier matrix 
brings an extra benefit to the delivery approach. Nanoparticles conjugated with 
antigens have been found to generate a stronger immune response compared to 
conjugation with the free antigen alone.143,144
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6. Silica biodegradation
Nanoparticles aimed at theranostic applications have to remain intact, i.e. tar-
geting and imaging groups, as well as the drug, have to remain associated with 
the particles until they have reached their site of action. Subsequently, degrada-
tion should take place to avoid carrier-induced toxicity. The rate of dissolution 
controls the detachment of the targeting ligands and the drug release profile, 
and therefore these parameters must be optimized for the application in ques-
tion. 
The solubility of amorphous silica in an aqueous medium is strongly de-
pendent on the pH, temperature, on the degree of material condensation, spe-
cific surface area, and functionalization. Moreover, amorphous silica can occur 
in variable forms, which makes the mapping of the dissolution process chal-
lenging. Until now, a single pattern for the dissolution profile of amorphous 
silica has remained unclear. 
In the dissolution process the silica network will depolymerize through hy-
dration, hydrolysis, and ion-exchange processes.51 The chemical stability of sili-
ca significantly decreases in alkaline conditions, as the dissolution is promoted 
by water OH– anions attacking silanol groups in the material.145
Etienne et al. studied dissolution of native- and aminopropyl-grafted mi-
cron-sized mesoporous silica in water under biologically relevant pH condi-
tions. The amino-functionalized silica dissolved at a faster rate than the native 
particles did and in 4 h, ⅔ of the amino-groups were found in the supernatant, 
after which the concentration of amino species in solution reached a plateau. It 
is important to note that particle properties such as surface charge can be dra-
matically influenced during the dissolution process. The fast dissolution was 
suggested to originate from the breakage of the chemical bonds between the 
aminopropylsilane and the silicon atom (Figure 28).146 
silicon concentration measured as a function of
time in suspensions containing, respectively, an
unmodified silica gel in the presence of BuNH2
(curve a) and the APS material (curve b), during 2
days. In agreement with what was observed
previously (Fig. 5A), a sharp increase of the
soluble silicon appeared during the first 250 min
(/4 h) when the APS material was suspended in
the buffer solution, while a continuous slow
dissolution of the unmodified silica was observed
over the entire time range (Fig. 4B, curve b). After
the first 4 h, the degradation rate of APS was
slower, displaying a speed of dissolution compar-
able to that of unmodified silica gel. The dissolu-
tion of the unmodified silica gel in this medium is
owing to the high ionic strength generated by the
buffer [33,51], while this parameter is not rate-
determining in the dissolution of APS. The inset in
Fig. 4B depicts the difference between curves a and
b. It allows clearly to distinguish a breakthrough
during APS dissolution in aqueous medium: a fast
degradation at short time due to the presence of
amine groups in the material, followed by a slow
dissolution at longer times similar to that of
unmodified silica. Steady state situation appears
after several hours.
Because of possible destruction of the Si/O/Si
bond by nucleophilic attack of amine groups
(catalyzed by water molecules), one can suggest
that liberation of silicon in solution arises from the
deterioration of chemical bonds between the silane
layer and the silica surface leading to leaching of
free aminopropylsilane. This is expected to occur
to the substrate which is either singly, doubly, or
triply bonded to APTES; the last step being
illustrated by the following equation:
Indeed, the amount of aminopropylsilane that
has leached out of APS after 4 h equilibration in
aqueous medium (i.e., just before the break-
through in curve b of Fig. 4B) is about 0.9 mmol
g1, which is less than the initial loading of the
APS material used for this experiment (1.7 mmol
g1). Aminosilane liberation, however, cannot be
the sole mechanism involved in the degradation
process as the quantity of silicon in solution after
48 h equilibration is higher than 2 mmol g1,
which exceeds the amount of APTES that has been
grafted on the material. Some other silicon-con-
taining species originating from the bulk material
have also passed in solution. To distinguish
between these two processes, the quantity of amine
liberated in pure water (drastic conditions con-
cerning the stability) has been determined by
potentiometric titration (Fig. 6, curve b). By this
way it is possible to characterize quantitatively the
extent of leaching of aminopropylsilane in solu-
tion, as a function of time, and to compare it with
the amount of total soluble silicon. As shown, a
fast liberation of aminosilane was observed during
the first 2 h with the APS material in solution. A
steady state was reached after typically 4 h and did
not change later on, even after several days (data
not shown). The quantity of amine liberated at the
equilibrium does not correspond to all the amino-
(3)
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Figure 28. The breakage of the chemical bonds between the aminopropylsilane 
and the silicon atom leads to a faster dissolution process of aminofunctionalized 
mesoporous silica compared to that of native silica.146
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The influence of the immersion time of mesoporous silica nanoparticles 
with sizes ranging from 200–800 nm in simulated body fluid, SBF, on the struc-
ture of the particles was studied by Onida et al. They reported a rapid decrease 
in the mesopore volume during the first hours after immersion; simultaneously 
signs of ordered mesoporous structure were still visible in x-ray diffraction 
(XRD) pattern. The authors proposed that the dissolved silica is re-deposited 
close to the mesopore openings gradually closing the pores. Further support 
for this claim was obtained from drug-release kinetic measurements, where the 
drug-release rate reached a plateau at times corresponding to the time at which 
the mesopore volume was strongly diminished. Similar to observations pre-
sented by Onida et al., decreased drug-release rates connected to silica dissolu-
tion behavior has also been observed for micron-sized mesoporous silica.148
He et al., who obtained similar results to Onida et al., illustrated a three-
stage dissolution process for mesoporous silica in SBF. During the time below 
1 h a relatively fast “initial burst” takes place. Then deposition of a calcium and 
magnesium silicate layer drastically decreases the degradation rate. The third 
stage of dissolution involves a slow diffusion of dissolved silica species detected 
as free Si. The whole sample was degraded after 15 days when immersed at 
a concentration of 0.5 mg/mL. Importantly, they reported an intact particle 
morphology up to 24 h even though hollowing out and enlargement of the 
mesopores was clearly observed (Figure 29).148,149 
There are very few studies related to in vitro cell degradation of silica nano-
particles. Degradation after particle uptake is of high importance as external 
factors such as the local pH in one biological environment compared to an-
other varies remarkably, e.g. degradation in different cell compartments intra-
cellularly takes place. Zhai et al. studied the degradation process by incubating 
Figure 29. Schematic illustration of the degradation process of mesoporous 
nanoparticles in SBF. The highly-ordered hexagonal mesoporous structure 
degrades into a disordered network. The remaining walls are the result of the 
protective calcium/magnesium silicate layer deposited on the surface, which is 
illustrated by green dots in the 2nd stage and green lines in the 3rd stage.149
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hollow mesoporous silica particles with a size of 300–430 nm in SBF in vitro 
with human umbilical vein endothelial cells (HUVEC). During the first day 
particle degradation took place in the cytoplasm and lysosomes, and after two 
days in the lysosomes only. Inductively-coupled plasma optical emission spec-
troscopy (ICP-OES) measurements indicated an increasing Si content in the 
culture medium over time. This suggests an ongoing degradation process in-
side the cells and also demonstrates that cells can excrete the degraded product 
into the culture medium.150
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Characterization techniques
The characterization of amorphous silica is challenging because the structure 
of the materials is enormously complex. Typically several techniques are used 
in combination to provide detailed and unambiguous structural information 
for the material. 
The standard characterization of periodically-ordered mesoporous silicas 
include use of electron microscopies, small angle X-ray scattering (SAXS), 
small-angle x-ray diffraction (SAXD), gas adsorption analysis, and dynamic 
light scattering (DLS). Gas adsorption measurements are used to determine 
surface area, pore size, and pore size distributions. SAXS/SAXD can be used 
to determine the periodic-ordered structure of the material. The particle mor-
phology is typically studied by scanning electron microscopy (SEM), while the 
ordered arrangement of pores can be detected by transmission electron mi-
croscopy (TEM). Important characterization technique used for the evaluation 
of fluorescently-labeled nanoparticles’ specificity towards their target cells is 
fluorescence activated cell sorter (FACS) and a widely used technique to study 
their fate in biological environments is confocal fluorescence microscopy. 
In the following section the characterization techniques used will be dis-
cussed at a level that is required for understanding the results that will be dis-
cussed.
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7. Small angle x-ray diffraction
This technique is based on diffraction of x-rays by the electron clouds of the 
atoms in the sample. In the absence of absorption, the intensity of the scat-
tered radiation is directly proportional to the electron density differences in the 
system. When an x-ray beam with a wavelength λ strikes a crystalline solid or 
a material with a periodic long-range order, the Bragg conditions are fulfilled 
and constructive interference occurs. Selective reflections of intensity for (hkl) 
planes will be observed in a diffractogram when the glancing angle satisfies 
Bragg’s law (Eq. 5).
Where n=integer number of wavelengths (order of diffraction), λ =wavelength, 
dhkl = repeating distance between reflecting planes and θ=scattering angle.
Bragg’s law relates the distance between crystal lattices d with the observed 
reflection angle. In the law the scattered intensity is measured as a function of 
scattering angle θ. Compounds with different unit cell parameters have dif-
ferent lattice spacing, and therefore different diffraction patterns will be ob-
served for various materials. Thus the combination of d-spacing and intensities 
is characteristic for the structure in question. Furthermore, by analyzing the 
positions of the reflected beams, information about the size and symmetry of 
the lattice dimensions can be observed.
The periodicity of the material results in the diffraction phenomena. There-
fore, XRD can also be used to analyze the material structure, i.e. the pore ar-
chitecture of ordered mesoporous materials. Ordered amorphous mesoporous 
materials show reflections only in the low-angle range. Hexagonally ordered 
p6m structured materials such as MCM-41 and SBA-15 result in an x-ray pat-
tern containing three or more low-angle reflections. The p6m structure is in-
finite in the c-direction, which results in the absence of periodicity along the 
c-direction and therefore only (hk0) reflections are detected. 
MCM-41 material reflections correspond to their hexagonal space group 
p6m, which can be indexed to a hexagonal hk0 lattice and are, therefore, in-
dexed as (100), (110), (200), (210) and (300). A few characteristic x-ray patterns 
of some commonly observed mesoscopic structures are illustrated in Figure 
30. The d-spacings of mesoscopically ordered 2D hexagonal and lamellar silica 
materials are illustrated in Figure 31. The (100) direction of 2D hexagonally-
ordered materials is presented in Figure 32.
(eq. 5)
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Figure 30. Presentation of typical x-ray diffraction patterns of some common 
mesoporous material structures.36
Figure 31. A schematic illustration of hexagonal and lamellar silicate-surfactant 
structures and their reflection planes, which yield their d-spacing.151
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approximately the same time as the discovery of MCM-41, an alternative approach to 
mesoporous materials was described by Yanagisawa et al.,19 using kanemite, a layered 
silicate, serving as the silica source. The material is designated as FSM-n (Folded Sheet 
Mesoporous Materials-n), where n is the number of carbon atoms in the chain of the 
surfactant used. MCM-41 and FSM-16 are very similar, with however some slightly different 
adsorption and surface properties.20 
 
100
110 
 
 
 
F igur e 2.2:  left) TEM image of MCM-41; r ight) representation of the hexagonal lattice. 
 
The standard use of transmission electron microscopy (TEM), X-ray diffraction (XRD) and 
adsorption analysis allow independent reliable characterization of mesoporous materials. The 
hexagonal arrangement of uniform pores can be visualized by TEM, as shown in Figure 2.2. 
The pore sizes usually vary between 2 and 10 nm depending on the surfactant chain length, 
the presence of additional organic co-surfactants, or post-treatments. The pore wall thickness 
is usually evaluated to be between 0.7 and 1.1 nm. MCM-41 type mesoporous silicas are 
highly porous and commonly show BET surface areas exceeding 1000 m2/g and pore volumes 
up to 1 cm3/g. The N2 sorption isotherm measured for MCM-41 is distinctive, being a Type 
IV isotherm which is generally observed for mesoporous materials3 (Figure 2.3), but with an 
unusually sharp capillary condensation step. 
Mesoporous silicon oxide materials synthesized by surfactant templating are sometimes 
described in the literature as crystalline solids because of  their long-range periodicity. This 
idea is, however, not quite correct since the pore walls of the materials always consist of 
amorphous silica, with neither short-range nor long-range order. Nevertheless, the regular 
arrangement of the pores can be considered as a kind of “ super-structure”  with long-range 
 6 
Figure 32. TEM image of MCM-41 type material (Left) together with a schematic 
illustration of the 2D hexagonally-ordered lattice (Right).36
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Mesostructured materials exhibit hexagonal, lamellar, or cubic meso-order. 
In a 2D hexagonal lattice the repeating distance d is related to the unit cell pa-
rameter a as
where a is the lattice parameter which, in the case of hexagonally-ordered phas-
es, means the distance between the centers of adjacent cylinders. 
(eq. 6)a = 2d100√
3
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8. Nitrogen physisorption
Adsorption of gas molecules (adsorbate) can be used to determine the sur-
face area, pore size distribution and pore volume of porous solids (adsorbent). 
Nitrogen physisorption process is described quantitatively by an adsorption/
desorption isotherm, representing the amount of adsorbed/desorbed N2 at a 
fixed temperature (77 K) as a function of pressure. Prior to the measurement, 
samples need to be outgassed to remove physisorbed molecules.
8.1. Porosity and classification of pores
According to IUPAC pores are classified according to their size.3 
•	 Macropores: pores with widths exceeding 50 nm 
•	 Mesopores: pores with widths between 2 nm and 50 nm
•	 Micropores: pores with widths between 0.7 nm and 2 nm 
•	 Ultramicropores: pores with widths not exceeding 0.7 nm
8.2. The physisorption isotherms
The amount of gas adsorbed by a defined mass of solid depends on the equilib-
rium pressure, the temperature, and the nature of the gas-solid system. IUPAC 
has classified porous materials into 6 main types that have their characteristic 
adsorption–desorption isotherms (Figure 33). The shape of these isotherms is 
based on the strength of the adsorbent–absorbate interactions and the type of 
porosity (or porosities) of the adsorbent. Type I shows steep uptake of nitrogen 
in low relative pressure, which is associated with the microporosity of the mate-
rial. Type II and III isotherms are typical for nonporous or macroporous adsor-
bents, their difference being strong or weak adsorbent–adsorbate interactions 
respectively. The same way of interacting differs also type IV and V porous ma-
terial from each other. Here the characteristic adsorption of nitrogen at higher 
relative pressures is related to capillary condensation inside the mesopores re-
sulting in the hysteresis effect of the adsorption–desorption branch. The shape 
of the hysteresis loop reveals additional information about the pore structure. 
The type VI isotherm is relatively rare. It involves the step-by-step adsorption 
of layers on a highly uniform surface. As stated above, the shape of the isotherm 
gives direct information about the adsorbent–adsorbate interactions (weak or 
strong), monolayer–multilayer adsorption, filling and emptying of the pores, 
pore structure (size and shape), and layer-by-layer adsorption. Generally, the 
adsorption process in mesopores is dominated by multilayer adsorption and 
capillary condensation, whereas filling of micropores (pores of molecular di-
mensions) is controlled by stronger interactions.152 The samples prepared in this 
study are MCM-41 mesoporous materials expressing the type IV isotherms.
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Figure 33. IUPAC classification of physisorption isotherms of porous solids.3
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The specific surface area of the material can be determined by the Brunauer, 
Emmett, and Teller (BET) method using the physisorption isotherm data.152 To 
do this it is necessary to draw the BET plot and form that derive the value of 
the monolayer capacity, nm.
The constant C is related to the sharpness of point B shown in Figure 33 and the 
value is sensitive to both surface polarity and to the presence of microporosity. 
The C-value lies normally between 50 and 200.152 The BET surface area can be 
calculated as long as the BET plot is linear and does not cut the y-axis at x=0 at 
y-values below zero. The calculation requires that am, the average area occupied 
by each molecule in the monolayer, has a known value. For N2 at 77 K the value 
of am is normally assumed to be 0.162 nm2. 
Furthermore, for vp the total specific pore volume can be obtained from the 
adsorption isotherm as a liquid volume adsorbed at the end of the pore filling. 
However, it is not always possible to obtain this value since the adsorption ca-
pacity “P/P0 approaches 1” depends on the magnitude of the external area and 
also the upper limit of pore distribution. In that case the isotherm does not 
reach its plateau at high relative pressures, the vp is obtained at a predetermined 
P/P0 close to 1.
The determination of pore diameter (pore width) of mesopores is based on 
the theory of capillary condensation and the application of the Kelvin equation.
where γ is the surface tension and Vm is the molar volume of the liquid. The 
equation shows the dependency between P/P0 and the mean radius of the me-
niscus rK. The radius of the cylindrical pore can be obtained by inserting the 
thickness of the adsorbed monolayer (t) to the value of rK. There are different 
calculation models available for pore size distribution of which the Barrett-
Joyner-Halenda (BJH) model is the most commonly used.154 However, the BJH 
method based on the Kelvin-Cohan equation underestimates the pore size by 
≈1 nm in the pore size range of 2–4 nm.155 Although the BJH model is inac-
curate in determining the absolute pore size, it is useful for comparing the pore 
sizes. A more accurate way of determining pore size distribution is the non-
local density functional theory (NLDFT).154,155 DFT is used to create equilib-
rium profiles for all locations inside the pore, by minimizing the free energy. 
The free energy potential includes attractive and repulsive contributions of the 
fluid-fluid and fluid-wall interactions, which can be obtained using the NLDFT 
theory. Finally, the experimental isotherm is compared with the single pore 
(eq. 7)P/P0
n(1− P/P0) =
1
nmC
+
C − 1
nmC
· P
P0
(eq. 8)ln
P
P0
= −2γVm
rkRT
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isotherms as determined by the theoretical isotherm calculations, which are 
based on the NLDFT method. The pore size distribution is obtained through 
fitting the experimental sorption isotherm to a linear combination of theoreti-
cal isotherms calculated for a given pore diameter. The weight coefficients of 
this fit are then used to determine the pore size distribution. 
All nitrogen sorption measurements in this work were performed with an 
ASAP 2010 instrument (Micromeritics), at 77 K. Autosorb 1 software (Quan-
tachrome instruments) was used to determine surface area by BET theory, and 
NLDFT theory was the basis for pore size and the pore size distribution calcu-
lations. 
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9. Electrokinetic zeta potential measurements
Zeta potential is an experimentally determined potential located in the prox-
imity of the particle surface. When a charged particle is suspended in liquid, 
ions of the opposite charge will be attracted to the surface of the particle. The 
net charges at the particle affect the distribution of ions in the surrounding 
interfacial region in such a way that an increased concentration of counter-ions 
exists close to the surface of the particle (Figure 34). The liquid layer surround-
ing the particle will hence consist of two parts: an inner region, or the Stern 
layer consisting of strongly adsorbed counterions, and an outer layer, or the 
diffuse region, where both positive and negative ions less firmly form a charge 
“cloud”. The electrical double layer consists of these two layers. 
The Stern layer is considered to be immobile so the particle and the ad-
sorbed ions form a stable entity, meaning that when the particle moves in the 
liquid due to gravity or an applied electric field, for example, the ions within this 
boundary move along with the particle. The outer region of the diffuse double 
layer allows travel of ions via electrical forces and random thermal motion. This 
boundary inside the double layer is called the surface of hydrodynamic shear or 
the slipping plane. The potential between the particle surface and the dispers-
ing liquid, varies in relation to distance from the solid surface. This potential, 
“close to the surface” at the slipping plane, is called the zeta potential. It is im-
portant to note that the zeta potential is an experimentally determined value 
and the precise quantitative meaning of “close” can not be defined. 
Zeta potential is an important quantity in colloid chemistry since its mag-
nitude gives an indication of the colloidal stability of the particle system. When 
the particles have a large negative or positive potential, the dispersion will resist 
flocculation and the colloidal system will be stable. The zeta potential varies 
strongly within the pH and therefore zeta potential should always be noted to-
gether with measured pH. Electrokinetic titrations can be utilized to determine 
the isoelectric point (IEP) of the system. The IEP is the pH point at which the 
net effective surface charge, i.e. the zeta potential, is zero. It is, therefore, the 
point where the colloidal system is least stable. Furthermore, the electrolyte 
concentration should also be taken into consideration, as added electrolyte will 
screen the surface charges reducing the thickness of the double layer and hence 
decreasing the absolute value of the zeta potential.44,156,157
62
9.1. Determination of zeta potential by electrophoretic 
light scattering
Electrophoresis is capable of measure movement of colloidal particles in an 
electric field. Migration of particles can be determined optically by microelec-
trophoresis where location of individual particles can be determined in respect 
of time to marks on a grid of microscope eyepiece. Combination of microscopy 
with photon correlation spectroscopy enables determination of particles in the 
range of 3 nm and 5 μm. 
In capillaries of microelectrophoretic cell, streaming potential takes place 
and the applied external voltage causes liquid in the cell to move, a phenom-
enon called electroosmosis. At a certain point x (x=r/√2) located between a cell 
wall and center of the cell is a stationary layer where particles move with their 
true velocity that origins solely from their own charge. An optical detection 
system, such as electrophoretic light scattering can be used to determine move-
ment of the particles. The movement of the particles follows certain frequency 
that relates to their charge. Measured frequencies are converted to electropho-
retic mobilities, velocities, and finally zeta potentials. The velocity (v0) equals 
the product of electrophoretic mobility (μE) and the applied electrical field (E0)
For calculating the zeta potential certain theoretical assumptions are neces-
sary. In the following modified Stokes-equation the electrical field is the driving 
force for the movement of the particles.
where Q is the charge of a particle, a is the radius of a particle, η is the viscosity.
The “thickness” of the double layer is determined by Debye-Hückel-param-
eter 1/κ
where e is the elementary charge, zi is charge of the ion and ε is permittivity.
(eq. 9)v0 = µEE0
(eq. 10)
v0
E0
= µE =
Q
6piaη
(eq. 11)κ =
√
4πe2
∑
niz2i
ϵ0ϵkT
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The dimensionless product κa represents the ratio of the particle radius to 
the thickness of the double layer 
where ζ is the zeta potential.
For low values of κa the Henry-function (eq. 12) approaches 1, for large 
values of κa the function approaches 1.5. These values correspond to the both 
borderline cases known as Hückel- and Smoluchowski equation. Smoluchows-
ki approximation is generally used for the calculation of zeta potentials of dis-
persed colloidal systems containing spherical particles.179
(eq. 12)µE =
2ϵζ
3η
f(κa)
Figure 34. A schematic illustration of the structure of the electric double layer 
according to the Stern theory.157
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10. Dynamic light scattering
Dynamic light scattering (DLS) is applied to determine the hydrodynamic size 
of a nanoparticle. Brownian motion moves particles at a certain speed, which 
is related to the size of the particles, defined by the Stokes-Einstein equation.
where k is the Boltzmann constant, η is the solvent viscosity, T is the absolute 
temperature, Dt is the diffusion coefficient and DH is the hydrodynamic diam-
eter of the particle.
When a sample is illuminated by a light source, such as laser, it scatters light 
in all directions. In this study DLS measurements were performed at 298 K, 
using a monochromatic laser, with a working wavelength of 632.8 nm and a 
non-invasive backscatter (NIBS), with the detector that is positioned at 173° 
relative to the laser beam. The speckle pattern is measured in relation to time, 
first within a certain time point t, next showing the fluctuation in scattering 
intensity at the time point (t+δ) continuing this way, always correlating the 
measured data to the previous one. According to the Stokes-Einstein equation, 
Brownian motion of the particles is slower for bigger particles than for smaller 
particles, which leads to slower fluctuation of intensity-speckle change for big-
ger particles. For the correlation, bigger particles fit for a longer time for the 
data collected from the previous data point, see Figure 35a. After the determi-
nation of the correlation function, it is possible to calculate the particle-size 
distribution, see Figure 35b. In the case of a sample consisting of particles in 
two size classes equal in number, the bigger particles scatter more light result-
ing in larger peak area by intensity. This results from the Rayleigh approxima-
tion, which describes the intensity of scattering to be proportional to the sixth 
power of the particle diameter. The size distribution of particles can also be 
determined by volume and by number (Figure 36). However, this data is gener-
ated from the raw data of the intensity.44,156,157
(eq. 13)
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Figure 35a. Illustrated is a dynamic light-scattering correlation function for small 
and large particles. The rate of decay for the correlation is related to the particle 
size.44
Figure 35b. Illustrated is a dynamic light-scattering correlation function for small 
and large particles. The rate of decay for the correlation is related to the particle 
size.44
Figure 36. A sample containing particles of two sizes, 5 nm and 50 nm, equal 
in number. Particle distribution is represented by number, by volume, and by 
intensity.44
66
11. Electron microscopy
The electron microscope operates on the same basic principles as the light 
microscope but uses electrons instead of light. Electrons have a much lower 
wavelength compared to photons, which makes it possible to get a resolution a 
thousand times better than with a light microscope.
11.1. Transmission electron microscopy 
Depending on the set-up, transmission electron microscopy (TEM) enables the 
study of objects to an ångstrom level, such as imaging small details in the cell 
or different materials down to near atomic levels, making it a valuable tool for 
medical, biological and materials research.
An electron beam is generated by an electron gun commonly fitted with a 
tungsten filament cathode as the electron source and accelerated by an anode. 
Electromagnetic lenses focus the electrons into a very thin beam focused on an 
ultra-thin specimen. 
Depending on the density of the material, some of the electrons are scattered 
and disappear from the beam. Electrons that transmit a specimen to a detector, 
provides a “shadow image” of the specimen with its different parts displayed in 
varied darkness according to the atom density in the sample. Electrons leaving 
the sample may have changed their direction, lost energy (inelastic scattering) 
or lost no energy (elastic scattering), or done both, even multiple times. Heavy 
atoms having high electron density result in more interactions between the 
electrons in the primary beam and those in the sample, which in turn provides 
a higher contrast in the resultant image. Biologic samples are often stained with 
heavy metals to increase their contrast in imaging.123, 158–160
11.2. Scanning electron microscopy
In scanning electron microscopy (SEM), scanning of the specimen surface 
with a focused beam of electrons forms an image of the specimen’s topography. 
Similarly to TEM, a high voltage electron beam is created by an electron gun 
and focused to the sample by electrostatic and electromagnetic lenses. Primary 
electrons of the electron beam can enter the sample and refract around one or 
several atomic nuclei, exciting the sample by nearly unchanged energy called 
backscattered electrons. Since the heavier nuclei refract more electrons, the 
method can be used to determine the atomic composition of a sample. When 
electrons from the beam hit the nuclei of an atom in the specimen, secondary 
electrons are formed and emitted from the sample. Due to the remarkably low-
er energy of secondary electrons compared to that of primary electrons only 
electrons excited close to the surface of the sample manage to leave it. When the 
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beam scans a small area of the specimen surface, scattered secondary electrons 
are collected and an image of the specimen topography is formed.158–160
Figure 37. A principal picture of TEM and SEM devices.161
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12. Confocal microscopy
The confocal laser-scanning microscope (CLSM or LSCM) is an instrument 
that is capable of constructing high-resolution images of 3D reconstructions of 
fluorescent samples. Fluorescent molecules absorb light of a certain wavelength 
and emit it at longer wavelengths. In the confocal microscope the light goes 
through excitation and emission filters wherein the wavelengths used depends 
of the fluorescent molecule used. 
The key feature of confocal microscopy is its ability to produce blur-free im-
ages of thick specimens at various depths. In this technique images are taken 
point-by-point and reconstructed by using a computer. The microscope selec-
tively collects images from a certain focal plane by using a directed beam of 
light from the laser. 
The confocal microscope is based on a laser beam that passes a light source 
aperture and is further focused by an objective lens into a small (ideally diffrac-
tion-limited) focal volume within a fluorescent specimen. A mixture of emitted 
fluorescent light and reflected laser light from the illuminated spot is recollect-
ed by the objective lens. A beam splitter separates the light mixture by allow-
ing only selected fluorescent wavelengths to pass while blocking the original 
excitation wavelength. The fluorescent light is then reflected into the detector 
(Figure 38). When the fluorescent light has passed a pinhole it is detected by a 
photo-detection device (photomultiplier tube (PMT) or an avalanche photodi-
ode) which functions by transforming the light signal into an electrical signal, 
which is finally recorded by a computer.
Confocal microscopy imaging of a biological system should be carried out 
in such a way that the system retains its normal function. To reduce the damage 
caused by light, studies with fluorescence benefit from collecting efficiently the 
emitted fluorescent light available. This is particularly important for studies of 
living cells because photodynamic damage and consequent alteration in nor-
mal cell behavior is a concrete possibility. 
It is common to incorporate multiple fluorescent probes within single cells 
or tissues in order to define the differential distribution of more than one la-
beled structure or molecular species. These types of multi-color or multi-
spectral imaging experiments require adequate separation of the fluorescent 
emissions, and this is especially problematic when the spectra are substantially 
overlapping. Various spectral imaging computational processes are utilized to 
separate the emitted light into its spectral components.
Confocal imaging in living cells is dependent on the properties and avail-
ability of suitable fluorescent probes, for which the most important proper-
ties are high binding specificity, strong signal, slow bleaching, and nontoxicity 
leading to a high signal-to-noise ratio. To solve these specific problems, the 
use of nanoparticles as imaging agents has the potential to provide remark-
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ably higher photostability and signal, compared to that of single fluorophores 
can produce thus enabling higher quantitativity in the analysis of the obtained 
data.147, 153, 162-163
Theory 
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To achieve a sharper image the detector aperture obstructs the light that is not 
coming from the focal point. The out-of-focus points are suppressed and most of 
their returning light is blocked by the pinhole. This feature makes the difference 
when compared a confocal laser microscopy to conventional fluoresence microscopy 
techniques and permits one to obtain images of various z axis planes (z-stacks) of the 
sample.  
 
 
 
 
 
Figure 19. Principle of a confocal microscopy [53].  
 
 
3.8.4.  Electron Microscopy 
 
There are two types of electron microscope –the scanning electron microscope 
(SEM) and the transmission electron microscope (TEM).  
 
Electron microscopy uses electron beam to form magnified images of specimen. An 
advantage in using electrons, compared to using light, is that electrons provide 
thousand fold increased resolving power. Resolving power of a light microscope is 
200 nm whereas that of TEM is 0.2 nm and for SEM 3 nm [54]. Imaging of the 
materials is dependent on the electron density of the material. Nano-structured 
materials are accessible with TEM and SEM but less electron-dense materials such 
as biological materials are mostly invisible [55].   
Figure 38. A schematic presentation of the principle of a confocal microscope.164
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13. Flow cytometry
Flow cytometry is a technique that is capable of simultaneously meas-
ure and then analyze multiple physical characteristics of single particles 
(d ≈ 0.2–150 μm), usually cells, as they flow in a fluid stream through a beam of 
(laser) light. The properties that can be measured include relative size of parti-
cles, their relative granularity or internal complexity, and their relative fluores-
cence intensity. The technique determines these properties using an optical-to-
electronic coupling system that records how the cell or particle scatters incident 
laser light and emits fluorescence.
In flow cytometry the fluidics system transports particles in a stream to the 
laser beam. The optics system consists of lasers to illuminate the particles in the 
sample stream and optical filters to direct the resulting light to detectors. The 
light that is scattered from the sample can be detected from various angles from 
the direction of a laser beam. Forward scattering (FCS) <10° from the direc-
tion of a laser beam tends to be more sensitive to the particle size and surface 
properties and is generally used to distinguish live and dead cells from each 
other. Side scattering (SSC) is detected from a 90° angle from the direction of 
a laser beam. SSC is used to detect the granularity of the cells. The electronics 
system converts the detected light into electronic data that can be processed 
by the computer. When the instrument is equipped with a sorting feature, the 
electronics system is also capable of initiating sorting decisions to charge and 
deflect particles.175–177
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14. Article I
The purpose of Paper I was to study the influence of surface modifications and 
further functionalizations on the dispersion stability of silica nanoparticles in 
physiological conditions. 
14.1. Construction of the model particle
A model system of nonporous, monodisperse silica nanoparticles with an av-
erage size of 240 nm was synthesized and further modified by various surface 
functionalization routes. To create sufficient functional surface groups on the 
intrinsic nanoparticle surface, first surface functionalization was carried out by 
hyperbranching polymerization of polyethyleneimine (PEI). Tethered polymer 
generally increases the number of anchoring groups for further conjugation. 
The relative amount of primary “accessible” amino groups in a PEI polymer 
was analyzed by using thermogravimetry and an imine method. Based on these 
analyses roughly 50 % of the surface-grown polymer amino groups turned out 
to have primary functions indicating that the polymer was fully branched to 
several generations. 
The electrostatic stability of particle dispersions with varying pH values can 
be characterized by electrokinetic titrations. A high positive zeta potential of 60 
mV of the PEI functionalized particles over a wide pH range, including also the 
neutral pH physiologically-relevant values, gave an indication of good dispers-
ibility of the particles by electrostatic means.
To enable the attachment of specific biotinylated antibodies, the particles, 
surface modified by streptavidin, either native or fluorescently labeled, was ac-
complished. This covalent functionalization was carried out according to three 
different functionalization routes (Figure 39). 
Streptavidin was attached to the PEI primary amino groups either directly 
(Route 3) or by using a glutaraldehyde (Route 1) or succinic acid (Route 2) as 
a linker molecule. To evaluate the dispersion stability, electrokinetic titrations 
were carried out for all streptavidin-conjugated particles in both water and sa-
line solution (electrolyte concentration equals to that of phosphate buffered 
saline, PBS). IEP values provided from the titrations are summarized in Table 1. 
The zeta potential changed according to the character of the conjugated sur-
face functions. As aldehyde groups are not dissociable groups, this conjugation 
did not directly contribute to the surface-charge density and zeta potential, but 
its effect could be seen as the amount of effective amino groups decreased, lead-
ing to the increase of a relative concentration of negative silanol groups on the 
particle surface. In Route 2 succinic anhydride was used as a linker to form 
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an amide bond between the linker molecule and particle, and then, further 
another amide bond between the linker and streptavidin. EDC (1-Ethyl-3-(3-
(dimethylamino)propyl)-carbodiimide) “zero-length linker” was used in the 
procedure to activate the carboxylic acid groups in order to enable subsequent 
conjugation of streptavidin. The converting of amino groups into carboxylic 
acid groups via succinylation could be seen as a clear drop of the particle IEP 
from 10.3 to 5.35. The intrinsic pKa for succinic acid is 4.16; therefore, the IEP 
of 5.35 indicates that not all of the amino groups were converted during the 
conjugation procedure. To compare the obtained values, an IEP of 3 has been 
reported for succinylated amino functionalized silica particles, where the ami-
no groups were introduced by silanization.14 In this study, the PEI is hyper-
branched polymer having also secondary and tertiary amino groups, which 
cannot be converted during the conjugation process but do contribute to the 
absolute surface charge of the particles. Moreover, streptavidin itself has an IEP 
of 5–7, which also explains the decrease of IEP. The IEP value presented in Ta-
ble 1 shows that particles that are conjugated directly, without a linker molecule 
between streptavidin and the particle, provide higher stability for the particle 
suspension compared to using a linker molecule.
All surface functions influence the zeta potential of particles. For this rea-
son, the influence of the type of fluorophore conjugated to the surface-bound 
streptavidin was studied in relation to dispersion stability. 
The direct linking Route 3 was employed to conjugate fluorescent streptavi-
din, labeled either with Alexa555 or Dylight549. The particle stability was eval-
Figure 39. Streptavidin was conjugated on the particles by employing three 
different surface functionalization routes.
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uated by conducting electrokinetic titrations, where zeta potential and particle 
size was measured in relation to the changing pH (Figure 40). While disper-
sions of particles conjugated with Alexa555-labeled streptavidin remain fully 
stable up to pH about 8, the conjugation with Dylight549 labeled streptavi-
din provides particles with an IEP of 7.9 leading to pronounced agglomeration 
within the biologically interesting pH range of 7–8. The Dylight fluorophores 
are synthesized through sulfonate addition, which makes these dyes negatively 
charged and hydrophilic. Dylight fluorophores are available as succinimidyl es-
ters, the same as for Alexa555. Both Alexa555 and Dylight549 are amine-reac-
tive dyes and are conjugated to free amino groups of the streptavidin tetramer, 
which means that the conjugation chemistry is similar. 
Confocal microscopy imaging was employed to evaluate the flocculation of 
the particles and the imaging characteristics of the differently conjugated parti-
cles (Figures 41–42). All of the particles prepared by different functionalization 
routes were fluorescing under the applied conditions, which indicated a suc-
cessful conjugation of the labeled streptavidin to the particle surface. However, 
Table 1. The obtained IEP values of streptavidin conjugated particles determined 
from electrokinetic titrations in water or saline solution (SS). The saline solution 
has the same ionic strength as physiological media (0.154 M).
Figure 40. Simultaneous electrokinetic titration for the determination of the 
particle zeta potential (■) and dynamic light scattering for the measurement of 
the particle size(▼). (On the left) SiO2-PEI-STV-Alexa555, IEP 9.3. (On the right) 
SiO2-PEI-STV-DyLight549, IEP 7.9.
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only Alexa555-streptavidin conjugated by employing the direct route 3 showed 
virtually no flocculation, which also agrees with the measured zeta potential. 
Successful linkage of streptavidin on the particle surface was also confirmed by 
TEM imaging (Figure 43). Here streptavidin was conjugated by biotin-alfa2 in-
tegrin antibodies labeled with protein A gold. Protein A gold could be observed 
on the particle surface, indicative of successful binding of the biotinylated an-
tibody to streptavidin.
Figure 41. (On the left) PEI-GA-STV(Alexa555) particles (0.01 mg/mL) in water. 
(On the right) PEI-Succinic Acid-STV(Alexa555) in water (0.01 mg/mL). The 
scale bar corresponds to 20 μm.
Figure 42. PEI-STV(Alexa555) (0.02mg/mL) in water. The scale bar corresponds 
to 20 μm.
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14.2. Summary of the results
Fluorescent streptavidin complex was linked on the surfaces of the prepared 
nanoparticles by utilizing three different conjugation routes. The results clearly 
show that the stability of the particle suspensions is crucially dependent on all 
functional groups present on the particle surface. The surface functions may ei-
ther directly affect the effective surface charge if the functions contain charged 
groups, or may indirectly affect them through relative concentration of charged 
groups on the nanoparticle surface. This introduced new methodology offers 
the means for fine-tuning the effective surface charge of the particles at a given 
pH, which is one of the key parameters for dispersion stability. 
Figure 43. (On the left) PEI-GA-STV(Alexa555) particles (0.01 mg/mL) in water. 
(On the right) PEI-Succinic Acid-STV(Alexa555) in water (0.01 mg/mL). The 
scale bar corresponds to 20 μm.
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15. Article II
The purpose of Paper II was to study the intracellular decomposition of func-
tionalized MSNs. The degradation and elimination of the particles from the 
body is important to minimize toxic effects of the carrier matrix itself. How-
ever, to fulfill their task, MSNs initially have to remain intact; the targeting and 
imaging groups, as well as the drug, have to stay associated with the MSNs 
until the particles reach their target site. A model system consisting of core-
shell-shell silica nanoparticles, to which different fluorophores were selectively 
covalently linked was used to study the degradation processes of the particles 
in vitro (Figure 44). Confocal fluorescence microscopy was used as the main 
technique to analyse the particle fate in and outside the cells.
15.1. Construction of the model particle
A three-layer particle structure was employed in order to enable tracking of the 
different parts of the particle in relation to the particle degradation as a func-
tion of time in vitro. 
Fluorescent isothiocyanate isomer I (FITC) was incorporated by co-con-
densation into the solid core of the particle, and similarly tetramethylrhoda-
mine isothiocyanate (TRITC) was co-condensed as part of the mesoporous 
shell. The surface of the particles was functionalized by surface-grown polyeth-
yleneimine (PEI) and a third fluorophore, Alexa633 NHS ester, was conjugated 
to the primary amino groups of PEI.
In the discussion of the results, the different fluorescence emission colors 
will be indicated together with their locus in the particles as follows: green (C) 
for FITC-core, yellow (MP) for TRITC-mesoporous shell, and red (PEI) for 
Alexa633-PEI.
Figure 44. A schematic illustration of prepared three-color core-shell-shell 
particles.
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15.2. Characterization by the set of standard techniques
The prepared three-layer fluorescent silica particles were characterized by ap-
plying several techniques in combination. The size of the prepared particles 
and their uniformity was determined by SEM and TEM imaging together with 
DLS. The core-shell-shell MSNs have a diameter of about 240 nm and a very 
narrow size distribution, as shown in a SEM image. The core-shell structure of 
the MSNs is clearly visible, and the mesoporous shell is uniform as observed 
from the TEM image (Figure 45).
A nitrogen adsorption-desorption isotherm of the core-shell particles meas-
ured prior to surface functionalization is shown in Figure 46. A pronounced 
uptake of nitrogen at a relative pressure close to 0.3 P/P0 is characteristic of 
mesophases synthesized using CTAB surfactant as a structure-directing agent 
and corresponds to filling mesopores having a diameter of about 4 nm with 
a narrow pore-size distribution. The specific surface area, obtained from the 
nitrogen physisorption data, was 344 m2/g, and the specific pore volume of 
the primary mesopores was 0.34 cm3/g. The pronounced uptake observed at 
the higher P/P0 is due to the filling in interparticulate porosity. The low-angle 
SAXD pattern exhibits a main reflection at 2.2° 2θ and additional intensity in 
the regions expected for (11) and (20) reflections of a 2D hexagonal mesophase, 
suggesting an ordered mesoporous surface layer. Assuming a 2D hexagonal ar-
rangement of pores, the lattice spacing derived from the (10) reflection is 4.83 
nm (Figure 47). 
The zeta-potential of co-condensed core-shell particles was -27 mV in 25 
mM HEPES pH 7.2, which increased to +52 mV after PEI functionalization. 
This indicates a successful attachment of the highly cationic PEI layer. The 
Figure 45. (On the left) SEM image of the core-shell-shell MSNs. The scale bar 
corresponds to 1 µm. (On the right) TEM image of the particles. The scale bar 
corresponds to 20 nm.
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content of PEI was analyzed by thermogravimetry. A mass loss of 7.1 wt-% in 
comparison to reference particles lacking PEI was shown. After attachment of 
the Alexa633 dye to PEI primary amino groups, the zeta-potential increased 
slightly to +55 mV. 
15.3. Local pH correlates to the fluorescence intensity of 
the highly pH dependent fluorescein isothiocyanate
In contrast to the other two fluorophores in the particle, Alexa633 and TRITC, 
the fluorescence of FITC is known to be strongly pH dependent due to the pKa 
of FITC being 6.4. Fluorescence intensity measurements using free FITC in 
buffers showed a decrease in the fluorescence intensity of about 50 % at pH 6.5 
and of about 85 % at pH 5.5 as compared to the intensities measured for the 
same FITC concentration at pH 7.5, which is in agreement with the values in 
literature.103 
Figure 46. (On the left) N2 physisorption isotherm for prepared core-shell particles. 
(On the right) N2 physisorption BJH pore-size distribution in the mesoporous 
layer indicates a uniform pore size.
Figure 47. The SAXD pattern measured for the core-shell particles indicate an 
ordered porosity of the mesoporous shell.
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When similar experiments were performed for the core-shell particles void 
of PEI, a FITC fluorescence intensity decrease of 60 % was observed at pH 5.5 
as compared to pH 7.5. Thus, the fluorescent intensity drop was lower than that 
of the free fluorophore. The smaller pH dependency of the FITC fluorescence 
emission intensity when incorporated into Stöber-type silica particles is tenta-
tively attributed to different local pH values experienced by the probe inside the 
Stöber particles,165 but these results also highlight that the Stöber-like particles 
are not completely nonporous, as external pH changes can indeed affect the 
dye. 
Importantly, no pH-dependent changes in the fluorescence intensity of 
FITC were detected for PEI-coated core-shell particles, which suggest that the 
presence of PEI buffered the pH inside the core-shell particles. These obtained 
results will be discussed further as a means of clarifying the detachment kinet-
ics of PEI from the MSNs, in addition to the analysis of the locus of the different 
fluorescent dyes. 
15.4. Evaluation of the particle degradation in vitro 
Confocal imaging, image analysis, and quantification was carried out to evalu-
ate the particles’ fate in vitro. Human SAOS-2 (sarcoma osteogenic) cells were 
incubated with the particles at a concentration of 125 μg/mL, and cell samples 
were taken at three points in time: 5 min, 1 h, and 4 h. Samples were fixed in 
paraformaldehyde for confocal imaging studies. 2D confocal images were ac-
quired both near the surface of the microscope glass and from the upper half 
of the cell. All three fluorophore excitation wavelengths (488, 543, and 633 nm) 
were applied, and images were recorded separately (multitracking). Regions of 
interest (ROI) were drawn onto the recorded images so that particles outside 
the cells were analyzed separately from particles inside the cells. In total ap-
proximately 40 images from inside and 40 from outside the cells were analyzed 
for each defined point in time. The segmented objects were analyzed for the 
intensities of each of the three wavelengths as well as for average object size. 
Co-localization studies were performed to analyze the relationships of the dif-
ferent colors inside the cells. For that procedure all pixels in the images were 
analyzed, unlike for that in the segmentation-based analyses. Co-localization 
analyses were completed by recording all six possible Manders’ co-localization 
coefficients and observing changes in these between the three time points: 5 
min, 1 h, and 4 h. All image analysis was performed with the BioImageXD soft-
ware.166 The obtained results were statistically analyzed with a t-test for unequal 
variances and sample sizes, and significance was noted on graphs as follows: 
ns = p > 0.05, * = p < 0.05, ** = p < 0.01, *** = p <0.001.
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15.4.1. Segmentations
All three fluorescent colors were segmented separately. The intensity of the 
yellow channel showed the highest stability over the measurement time. 
Therefore, intensities of all colors were measured based on the yellow chan-
nel segmentations; that is, pixels having yellow fluorescence were used as the 
basis of the total intensity of the green and red fluorescence, and the intensi-
ties were normalized against the total yellow fluorescence intensity. In these 
measurements no significant changes in the dye intensities outside the cells 
were detected over time. These segmentation results suggest that particles lo-
cated extracellularly remained stable or dissolved in a homogeneous manner 
(Figure 48). 
Particles were internalized already at the 5 min time point, and the number 
of internalized particles increased with time in accordance with the literature. 
The time-dependency of the fluorescence intensity measured for the three dif-
ferent fluorophores originating from particles located inside the cells followed 
a different pattern. While the total fluorescence emission intensity of the yellow 
(MP) remained constant over time, a clear decrease in the corresponding total 
intensities of the red (PEI) and the green (C) was observed with increasing 
incubation time. The decrease in the red (PEI) intensity, both in the individual 
segmentations and when normalized against the intensity of the yellow fluo-
rescence, is consistent with a partial detachment of PEI from the particles with 
time, together with dilution of the surface-detached PEI, possibly due to en-
dosomal escape.64,167 Moreover, the decrease also in the green (C) fluorescence 
intensities over time supports this suggestion. As noted in the discussion above, 
FITC fluorescence intensities decrease with decreasing pH in the absence of 
pH-buffering PEI polymer on the particles. 
Figure 48. Intensity of the segmented objects over the observation time, measured 
both inside and outside the cells. (On the left) All of the colors are segmented 
in relation to the yellow channel inside the cells. (On the right) All colors are 
segmented in relation to yellow channel outside the cells. In the figures [ns] 
stands for non-significant change, and stars (*), up to three, describe the degree of 
significant change. (yellow ■, red ●, green ▲).
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15.4.2. Co-localizations
Co-localization analyses of all three fluorophores were executed to obtain 
more detailed picture of the particle degradation process in and outside the 
cells. The results are expressed as Manders’ coefficients, measuring two colors 
at a time. The number of pixels that contain both fluorescent colors is deter-
mined, and the total intensity of a given color within these pixels is divided by 
the total intensity of one or the other color within that segment. For example, 
the Manders’ coefficients of red toward yellow and yellow toward red do not 
necessarily give the same result. This is due to the fact that red could be com-
pletely co-localized with yellow, which would correspond to a Manders’ coef-
ficient of 1, while yellow pixels might not coincide with pixels showing both 
red and yellow, resulting in a Manders’ coefficient less than 1. It should also 
be noted that the determined Manders’ coefficients are more sensitive to sta-
ble particles as compared to potentially detached fluorophores, the detached 
fluorophores being diluted and thus falling below the set threshold values. This 
implies that intracellular analyses are more sensitive to colors remaining inside 
cellular compartments rather than being located in the cytoplasm. 
Separate co-localization analyses were carried out separately for particles 
located inside as compared to outside the cells. The changes in the Manders’ co-
efficients in relation to the measured time for particles located outside the cells 
were within experimental error.  The results suggest that the particles contained 
all fluorophores throughout the experiment. However, this does not mean that 
there was no particle dissolution but that the particles did at least not com-
pletely disintegrate nor did any of the layers completely detach from the main 
particle during the time observed. Similar to the segmentation analyses, inside 
the cells the co-localization was quite different. 
The Manders’ coefficients of all color combinations inside the cells are shown 
in Figure 49. The co-localization for green(C)-yellow(MP) is high over the time 
of observation, while the corresponding values for yellow(MP)-green(C) de-
crease significantly over time. This result suggests that the mesoporous silica 
layer is detaching from the main particles, and leaves some of the mesoporous 
layer behind. Also co-localization for red(PEI)-yellow(MP) is high through-
out the experiment, while the Manders’ coefficient for yellow(MP)-red(PEI) 
decreases in a significant manner over time. This result is consistent with a 
process where the mesoporous layer is dissolved in a way that some of the 
mesoporous silica layer is detaching together with the PEI layer from the par-
ticles, and at the same time a portion of the mesoporous silica layer remains 
associated with the main particle. This is also indicated by the high Manders’ 
coefficient for green(C)-yellow(MP) throughout the experiments. Interest-
ingly, the co-localization for red(PEI)-green(C) and green(C)-red(PEI) can-
not be explained by using this simple dissolution model. The co-localization of 
green(C)-yellow(MP) remains throughout the experiment, as expected based 
on the values of the Manders’ coefficients, while the co-localization is signifi-
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cantly decreasing for yellow(MP)-green(C) with time. This suggests that the 
core is separating from the PEI layer, while the PEI layer remains on the Stöber 
particle core. The finding can be explained by a coexistence of particles where 
some fraction of the core-shell-shell particles have lost their PEI layer, while 
some particles still have a PEI layer on them. In accordance to the discussion 
above, the detachment of PEI, which is also supported by the time-dependent 
total fluorescence intensity analysis, together with the escape of PEI into the 
cytoplasm, will lead to an overestimation of the amount of PEI present in in-
tracellular compartments. PEI may be attached to particles or to fragments of 
mesoporous silica particles still present within intracellular compartments. As 
a conclusion, the results clearly suggest that the PEI layer is detaching from the 
particles, most probably both in the form of free PEI and PEI attached to frag-
ments of mesoporous silica, and that this degradation process preferentially 
occurs inside the cells. 
An illustration of the suggested intracellular degradation process of the 
core-shell-shell particles is given in Figure 50. These results do not allow for 
a more detailed analysis of the nature of the intracellular compartments such 
as different types of endosomes and lysosomes. However, the preferential in-
tracellular detachment of PEI from the particles, do give clear support for the 
intuitive claims based on drug release studies that PEI must detach from the 
Figure 49. Calculated Manders’ co-localization coefficients as a function of 
incubation time (a) for (red/green ■, green/red ◆), (b) for (green/yellow ■, yellow/
green ◆), and (c) for (red/yellow ■, yellow/red ◆).
a) b)
c)
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particles inside cells, providing a means for an intracellularily-triggered drug 
release. Furthermore, this mechanism seems to be operational irrespective of 
whether the drug is covalently linked to the PEI layer or if the drug is physically 
adsorbed into the mesopores of the MSNs, here referring to a previous study 
where MTX was delivered in vitro by using fully mesoporous nanoparticles.107
15.5. Summary of the results
The obtained results clearly suggest that the PEI layer is detaching from the 
core-shell-shell particles, most probably both in the form of free PEI and PEI 
attached to fragments of mesoporous silica and that this degradation process 
preferentially occurs inside the cells. The results also suggest that the disso-
lution process is mainly driven by the dissolution of the mesoporous silica 
shell. These results further suggest that covalent attachment of drugs, target-
ing groups or other functionalities and their subsequent intracellular detach-
ment is a promising route towards intrinsically-triggered intracellular release. 
Finally, these results demonstrate that new imaging-based methodologies can 
be used to effectively analyze the degradation of nanoparticles inside cells.
Figure 50. A schematic illustration of the suggested disintegration process of 
particles located inside the cells. 
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16. Article III
The purpose of Paper III was to demonstrate the targeting of nonporous mono-
clonal antibody-conjugated nanoparticles in vitro. The principle of the model 
system introduced in Paper I. Fluorescent nanoparticles are functionalized 
with biotinylated integrin α2β1 monoclonal antibody-streptavidin complex for 
targeting α2β1 stably expressing SAOS-2 cells. 
Because the targets of many drugs are located in specific intracellular com-
partments, medically-used nanoparticles should not only bind to the cell sur-
face and be internalized, but also find their way to the right location inside 
the cell. Due to these specific needs, the aim of the study was also to examine 
whether it is possible to guide nanoparticles into cells via a specific entry route 
that is characterized in a receptor-specific manner for the antibody used.
16.1. Construction of the model particle
Nonporous amino-FITC co-condensed silica nanoparticles with an average 
size of 70 nm (determined from SEM image) were synthesized by a Stöber pro-
cess. The surface of the particles was functionalized by fluorescent streptavi-
din by using homobifunctional α,ω-Bis-NHS-PEG, Mw 3000 as a cross-linker 
between the particle-surface amino groups and the fluorescent-streptavidin 
amino groups. A PEG linker was utilized in order to provide steric stability and 
to minimize unspecific protein adsorption to the particles. The particle surface 
was finally modified with an α2β1 integrin-specific antibody capable of recog-
nition of α2β1 integrin (Figure 51).
16.2. Characterization by the set of standard techniques
SEM and DLS were applied to analyze the morphology of the particles and 
their dispersibility, respectively. The successful surface modifications and 
imageability, were analyzed by electrokinetic measurements and confocal mi-
croscopy. Similarly to Paper II, confocal microscopy co-localization and seg-
mentation studies were undertaken to analyze the cell-particle samples. 
The hydrodynamic size of the particles was determined by intensity to en-
sure the uniformity of the particles after each conjugation step. After the attach-
ment of PEG, the hydrodynamic size was about 130 nm with a polydispersivity 
index (PDI) of 0.08. After attachment of PEG-streptavidin to the surface, the 
hydrodynamic size by intensity increased to about 170 nm, with a PDI of 0.124.
Surface functionalization can be followed with zeta potential measure-
ments; the zeta potential for amino-FITC functionalized particles was 30 mV, 
which increased to 42 mV after the particle-surface modification with PEG 
and streptavidin. As the pI of streptavidin is, depending on the reference, in the 
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range of 5–7, the increase of the zeta potential after conjugation gives an indica-
tion of successful surface functionalization.
16.3. Targeting of the particles in vitro
16.3.1. Flow cytometry
In the final surface modification step, the streptavidin-functionalized particles 
were conjugated with biotinylated antibodies, either a monoclonal antibody 
against the integrin α2-subunit “α2-particles” or a negative control antibody 
against NS-1 (not present on the SAOS-2 cells, “control particles”). The α2-
particles or control particles were incubated with the cells for 30 min, after 
which the attachment of the particles to the cell surfaces was determined using 
flow cytometry. The obtained flow cytometry results indicate that α2-particles 
were specifically bound to the cell surface, whereas control particles showed 
only weak binding, similar to cell type-dependent background levels (Figure 
52). 
16.3.2. Confocal microscopy and image analysis
16.3.2.1. Co-localization of the α2-conjugated particles with α2β1 integrin 
To further determine the co-localization of the α2-conjugated particles with 
α2β1 integrin, the cell surface was analyzed with 3D confocal imaging-based 
co-localization studies. Co-localization studies were conducted according to 
Figure 51. (On the left) A SEM image of the prepared Stöber-like nonporous 
nanoparticles. The scale bar corresponds to 100 nm. (On the right) A schematic 
representation of the particle structure. Particles were co-condensed with amino-
organosilane and FITC while the surface was modified by a homobifunctional 
PEG cross-linker connecting the fluorescent streptavidin on the particle. 
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the principles presented in Paper II. Both particle types, α2-particles and con-
trol particles, were analyzed for co-localization with α2β1 integrin. To detect 
the FITC-labeled particle location in respect to the target receptor, α2β1 integ-
rin receptors were immunolabeled with Alexa555-coupled secondary antibod-
ies. 
The co-localization was analyzed in a quantitative manner, whereby it was 
quantified by segmenting the particle channel, followed by calculating the ra-
tio of the integrin channel intensity within the segmented particles as com-
pared to elsewhere in the cell. The applied particle concentration was doubled 
(250 μg/mL) to allow for more unspecific control particle-binding and prop-
er comparison of the clustering effect between samples measured at the time 
points of 15 min and 60 min. To interpret the obtained data, a result of 1 would 
indicate the same amount of integrins at the particle sites as elsewhere in the 
cell and therefore no co-localization, whereas a number larger than 1 would 
indicate a higher amount of integrins at the particle sites than elsewhere. Both 
studied time points showed values close to 1 for the control particles, whereas 
α2-particles showed significant co-localization with the α2β1 integrins. Ob-
tained results confirmed that the α2 antibody-containing nanoparticles could 
be specifically targeted to α2β1 integrin-positive cells (Figure 53). 
16.3.2.2. Clustering of integrin receptors
Characteristic of the α2β1 integrin receptor-substrate interaction is receptor 
clustering followed by internalization of the clusters. Here, confocal studies 
were carried out to determine whether α2 antibody-conjugated particles could 
also induce such clustering. Again, the applied particle concentration was dou-
bled (250 μg/mL) to allow for more unspecific control-particle binding and 
Figure 52. Flow cytometry. (On the left) The flow cytometry volume plot shows 
attachment of α2-particles to the cell surface. The attachment of control particles 
is observed in a remarkably weaker manner. (On the right) The flow cytometry 
histogram of two repeated experiments represents the attaching of α2-particles 
to the cell surface in a considerably increased manner compared to that of the 
control particles.
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proper comparison of the clustering effect between samples measured at time 
points of 15 min, where the clusters are typically very prominent.168 The cells 
were stained with CellTracker Orange. Both particles and the cell membrane 
were segmented for the 15 min time point after which three central parameters 
for the clusters were quantified: intensity, volume, and number per cell sur-
face area. During clustering the first two parameters should increase, whereas 
the last one should decrease.166 Clusters of the particles conjugated with the 
α2-specific antibody were much brighter and larger but fewer in number than 
those of the control particles. Thus, α2-particles clustered significantly more on 
the cell membrane than control particles. This is probably due to the underly-
ing integrin clustering. These results confirmed that the particles were attach-
Figure 53. Co-localization was quantified by segmentation-based confocal 
imaging. As seen from the diagram, there was significantly more integrin signal 
at the α2-particles than elsewhere in the cell. No such difference could be detected 
with the control particles. Twenty cells were analyzed for each sample. The 
p-values were following:  < 0.05 (*), < 0.01 (**), and < 0.001 (***), “ns” is equal to 
“not significant”. Error bars in the presented figures are standard errors.
Figure 54. Quantification segmentation-based analysis of the particle clusters 
at the 15 min time point. Clusters were significantly larger, brighter, and fewer 
in number with α2-particles than with control particles, all indicating stronger 
clustering with α2-particles than with control particles. Twenty cells were analyzed 
for each sample.
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ing to the integrins in a manner that could potentially trigger their internaliza-
tion also.
16.3.2.3. Particle Internalization by α2β1 integrin positive cells
While forming clusters, α2β1 integrin is also internalized into the cell.166,169 3D 
confocal microscopy studies were conducted to study whether the nanoparti-
cles were similarly internalized. For these studies the original particle concen-
tration of 125 μg/mL was applied. To determine the internalization, both the 
particles and the cell membrane were segmented from the images, and the per-
centage of particle voxels inside the membrane was calculated.166 Significantly 
more of the α2-conjugated particles than control particles were internalized 
both at the 15 min and 1 h time points (Figure 55). Over the incubation time 
the percentage of internalized particles increased, as expected. However, the 
increase was larger for α2-particles than for control particles. Using clustering 
studies the experiment was repeated with doubled particle concentration of 
250 μg/mL. To enable more control particles to be analyzed and to see whether 
specific internalization could still be observed at higher particle concentrations 
also. As expected with the higher particle concentrations there was an increased 
unspecific entry of the control particles and at the 15 min time point there was 
no longer a difference between the two types of particles. At the 1 h time point, 
however, significantly more internalization was observed with α2-conjugated 
particles and an increase in their internalization over time was higher.
The specific internalization of the α2-conjugated particles was further con-
firmed with flow cytometry. To determine the fraction of internalized particles 
from those sitting on the cell surface, the outside fluorescence was quenched 
with Trypan blue, and thus only the fluorescence from internalized particles 
recorded. Obtained results indicate that significantly more α2-conjugated par-
ticles than control particles were internalized (Figure 56).
Interestingly, when comparing these results to the results of the earlier flow 
cytometry results, only a small portion of the cell-surface bound control parti-
cles seems to be internalized when compared to the same ratio for α2 particles. 
This suggests that even though there is some unspecific cell-surface binding of 
Figure 55. Particles were specifically internalized into cells via α2β1 integrin 
determinded by quantitative confocal segmentation studies. (On the right) 
Particle concentration was doubled and the experiment repeated.
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the control particles, the endocytosis of the particles is more specific than the 
surface-binding. In turn, this would give support to the usefulness of targeting 
nanovehicles to endocytic receptors for effective endocytosis.170
16.3.2.4. Intracellular trafficking 
Finally, the aim of the investigation was to clarify the internalization mechanism 
of the α2-particles. This was done by confocal co-localization studies based on 
the same principles as introduced above. Co-localization of α2-particles was 
determined using seven known internalization markers: Caveolin-1 for the 
caveolar pathway; monosialotetrahexosylganglioside (GM1) for the macropi-
nosytosis pathway; Transferrin 2 (TFR2), Rab5 (early endosomes) and Early 
endosome antigen 1 (EEA1) for the clathrin-mediated pathway; Rab7 for late 
endosomes; and Lysosomal-associated membrane protein 1 (LAMP1) for late 
endosomes and lysosomes. Each marker was visualized with antibodies linked 
to the Alexa555 fluorescent dye and imaged one-by-one together with the flu-
orescent nanoparticles. Imaging was conducted at the time points of 15 min 
and 1 h. Based on earlier studies, integrin α2β1 is thought to internalize via 
a macropinocytotic mechanism into Caveolin-1 positive structures and fur-
ther into late endosomal structures.168,169,171 In accordance with these results, 
α2-particles were determined to co-localize significantly with the macropino-
cytosis marker GM1, Caveolin-1, and Rab7, a typical late endosome marker 
(Figure 57).
Figure 56. (On the left) Flow cytometry volume plot shows considerably more 
internalization of α2-particles than of control particles. (On the right) A flow 
cytometry histogram of two repeated experiments, indicates that α2-conjugated 
particles internalized in a considerably increased manner compared to that of 
control particles. In the experiment non-internalized surface-bound particles 
were quenched with Trypan blue.
90
16.4. Summary of the results
The results obtained by flow cytometry,  confocal microscopy and atomic force 
microscopy indicates that the α2 monoclocal antibody-conjugated nanoparti-
cles can be targeted specifically towards their receptor, α2β1-integrin. Quanti-
tative segmentation analysis of nanoparticle trafficking inside the cell indicates 
that the particles enter cells via a macropinocytosis-like process and end up in 
caveolin-1 positive structures, which is similar to the internalization process of 
α2β1 integrin-echovirus-1. 
The obtained results clearly support the potential of nanoparticles as tools 
for molecular imaging, as it was possible by an appropriate image analysis to 
conduct sensitive and complex analyses of the small fluorescent particles inside 
cells by using basic confocal microscopy images.
Figure 57. Particles were internalized via specific route(s) characteristic of 
α2β1 integrin-mediated internalization. The specific internalization route was 
determined by co-localization studies quantified by segmentation based confocal 
imaging. The diagram shows the fluorescence ratios for each marker compared to 
particles elsewhere in the cells.
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17. Article IV 
The purpose of Paper IV was to prepare mesoporous imageable and targetable 
silica nanoparticles with the aim of delivering a poorly water-soluble molecular 
drug, a gamma-secretase inhibitor (GSI) ({N-[N-(3,5-Difluorophenacetyl)-L-
alanyl]-S-phenylglycinet-butyl ester}) (DAPT). 
The regulation of Notch signaling in cells is of high interest as it is a key 
regulator of stem cells and is frequently over activated in various types of can-
cer. It is often linked to aggressive forms of cancer, making Notch an exciting 
therapeutic target. Notch is in principle “druggable” by γ-secretase inhibitors 
(GSIs), inhibitory peptides, and antibodies, but clinical use of Notch inhibitors 
is restricted because it causes severe side effects. There is, therefore, a demand 
for an alternative cancer-targeted therapy.
17.1. Construction of the particles
Amino-functionalized co-condensed mesoporous silica nanoparticles (MSN) 
were synthesized in two different sizes. The synthesis was modifiable in relation 
to the produced particle size, as H2O:MeOH ratio of 60:40 was used to obtain 
particles with a diameter of 250 nm while H2O:MeOH ratio of 50:50 was used 
to synthesize particles with a diameter of 350 nm. After extraction, particles 
were surface functionalized either with fluorescein isothiocyanate (FITC) for 
in vitro or Alexa750 succinimidyl ester for in vivo experiments. These func-
tional fluorophores reacted with the amino groups introduced into the par-
ticle structure during the co-condensation synthesis. Afterward, the particle 
functionalization was carried out by surface-grown polyethyleneimine (PEI) 
polymerization. As discussed, the PEI-layer provides an increased number of 
anchoring groups and therefore facilitates efficient further modifications such 
as coupling of high amount of the targeting ligands and increased suspension 
stabilization. In the next functionalization step the targeting ligand, folic acid 
(FA), was conjugated to the primary amino groups of PEI. Zero-length cross-
linker 1-ethyl-3-(3-dimethylaminopropyl carbodiimide (EDC) was used to ac-
tivate the carboxylic acid groups of FA to enable the forming of peptide bind-
ing. The drug loading with DAPT was conducted on vacuum dried, surfactant 
extracted particles by suspending the particles in cyclohexane. DAPT was dis-
solved in cyclohexane with either 1 or 5 wt-% with regard to the particle mass. 
17.2. Characterization by the set of standard techniques
SEM images of the prepared 200 nm MSNs and 350 nm MSNs confirms the 
uniformity of the particles (Figure 58). SAXD pattern measured at a low-angle 
2.2° 2θ reveals the ordered pore structure of the particles and, further, the ni-
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trogen sorption isotherm confirms the mesoporosity of the particles (Figure 
59). Calculated from the sorption data, the 200 nm-Alexa750-labeled particles 
have a specific surface area (BET) of 1116 m2/g, pore volume (Vp) of 0.65 cm3/g, 
and d-spacing (dp) of 3.5 nm determined by NLDFT. DLS measurements in 
HEPES buffer pH 7.2 of FA-conjugated fluorescent MSNs confirms their redis-
persibility after all functionalization and drying steps. The overlapping curves 
for given particle sizes shows curves measured at different times for the same 
particle batch. The zeta potential was measured in HEPES buffer giving values 
of 52 mV and 41 mV before and after the FA-conjugation indicating a success-
ful surface modification (Figure 60).
Figure 58. SEM images of particles used for intravenous injections. (On the 
left) 200 nm and (on the right) particles with an average size of 350 nm. 20kx 
magnification, scale bar 1 µm.
Figure 59. (On the left) SAXD pattern reveals the ordered pore structure of 200 
nm Alexa750 labeled particles. (On the right) Adsorption-desorption isotherm of 
200 nm-Alexa750 labeled particles.
Summary of the results
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17.3. Targeting of the prepared particles in vitro
17.3.1. Flow cytometry
The targetability of the particles was assessed in vitro by using cell-lines ex-
pressing different levels of the folate receptor (FR), and FR high (HeLa) and FR 
low (HEK 293) cells and applying either MSN-PEI-FA or MSN-PEI particles to 
the cells at a concentration of 10 μg/mL. The relative amount of endocytosed 
particles was analyzed by flow cytometry. To further assess the apoptotic cell 
death, the cells were incubated in the presence of 10 μg/mL nanoparticles for 72 
hours. Propidium iodide incubation was applied to reveal the fraction of dead 
cells. Results indicate that FA-conjugated MSNs were specifically taken up by 
the FR-expressing cells and were further shown to be non-cytotoxic (Figure 61) 
in agreement with previous results obtained for similar particles.107,76,173
Figure 60. (On the left) Particles were uniform in size. (On the right) Zeta 
potential was measured before and after functionalization.
Figure 61. The specificity of MSN-PEI-FA towards the FA receptor was assessed 
by applying particles on the cells in vitro by using cell-lines expressing different 
levels of the folate receptor (FR), and FR high (HeLa) and low (HEK 293) cells. 
Specific ligand-lacking MSN-PEI particles was used as a particle control. (On the 
left) FACS histogram presents that particles are targeted specifically to the FR 
overexpressing HeLa cells. (Y axis denotes mean fluorescent intensity (MFI)). On 
the right) No particle-induced toxicity was observed.
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17.3.2. Luciferase-based reporter assay 
The effect of using GSIs such as DAPT for therapeutic purpose is based on the 
following principle. When Notch binds to Jagged or Delta ligands, the Notch 
receptor is subjected to proteolytic processes that release the Notch intracel-
lular domain (NICD), which then translocates to the nucleus where it regulates 
Notch-dependent gene expression. The cleavage of NICD is mediated by the 
γ-secretase (GS) complex. In this way gamma secretase inhibitors (GSI) inhibit 
the cleavage process (Figure 62).
Luciferase-based reporter assay was used to determine cell-specific particle-
induced Notch inhibition. GSI-loaded MSNs conjugated either with or without 
folic acid (Figure 63) were used to determine the targeting and further inhibi-
tion of Notch activity. GSI-MSN-FA was determined to specifically block the 
Notch activity in a dose-dependent manner in FR-high cells as compared to 
FR-low cells. The targeting function was further confirmed as the Notch inhi-
bition was detected only in the FR-high expressing cells. Importantly, this also 
demonstrated the lack of premature leakage of the drug into the cell medium, 
as leakage into the medium would have inhibited Notch in FR-low cells (Figure 
64). To confirm further the lack of premature drug leakage, high-pressure liq-
uid chromatography (HPLC) was used to determine the concentration of the 
drug in medium under mimicked extracellular conditions. 
Figure 62. (On the left) A schematic presentation of the particle structure. (On the 
right) The principle of Notch inhibition induced by GS inhibitors. 
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17.4. Targeting enhances tumor penetration and retains 
MSNs at the tumor site in vivo
17.4.1. Peritumoral injections
Tumor accumulation of nanoparticles in vivo is facilitated by a combination 
of passive and active targeting. The main objective of active targeting is to en-
hance interactions with tumor cells to facilitate cellular uptake and retain the 
drug carrier within the tumor. To verify active targeting in vivo, FA-MSNs and 
PEI-MSNs, lacking the targeting ligand, were administered through peritu-
moral (p.t.) (20 mg/kg) injections in nude mice bearing subcutaneous MDA-
MB-231 tumors. In vivo tracking was facilitated through covalent attachment 
of the far-red fluorophore Alexa750 to the particles. All particle batches were 
prescreened with an IVIS set-up to determine the signal to concentration ra-
tio in order to ensure comparability between different particle batches. Af-
ter the administration, an enhanced tumor retainment and increased tumor 
Figure 63. Folic acid was used as targeting ligand.172
Figure 64. The luciferase reporter assay, which was carried out to determine the 
Notch activity in vitro. Particles were incubated 24 hours with FR-high HeLa cells 
and FR-low 293 cells. GSI-MSNs are particles loaded with 1 wt-% and 2.5 wt-% 
GSI. Control MSNs (Ctrl-MSNs) are particles containing no drug. The particles 
were FA-conjugated in all cases. The x-axis presents the particle concentration 
(n ≥ 3; mean ± SD), while y-axis denotes the relative luciferase units (RLU).
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penetration of FA-MSNs were observed as compared to that of PEI-MSNs 
(Figure 65a–b). This result was further supported by ex vivo analyses of isolated 
tumors (Figure 65c). To conclude, an improved tumor retention and penetra-
tion of MSNs in vivo were achieved through conjugation of targeting ligands.
Figure 65. a) Tumor accumulation and retention of PEI-MSN-FA nanoparticles. 
PEI-MSN-FA and PEI-MSN used as control were injected p.t. and followed by 
IVIS imaging for 72 h. Scale bars in the images range from 300 to 8000 counts for 
images 30 min to 72 h. The control image is taken before the injection and has a 
scale bar of 200 to 4500 counts. b) Quantification of the fluorescence intensity in 
tumors injected with FA-MSNs and PEI-MSNs over time as related to the initial 
intensity within each tumor (n = 6, two tumors per animal) (*P < 0.05). c) Ex 
vivo imaging of internal organs and tumors 72 h after injection of MSNs. The 
tumors were further cut in half to visualize particles within the tumor tissue.
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17.5. GSI-loaded MSNs show enhanced Notch inhibition as 
compared to a free drug in vivo
17.5.1. Peritumoral injections
To verify the applicability of MSNs for delivery of GSIs in vivo, the therapeu-
tic efficacy GSI-loaded FA-tagged particles (GSI-MSNs) was validated in mice 
bearing MDA-MB-231 tumors expressing high Notch activity. The therapeu-
tic efficacy of particle-mediated GSI delivery was compared to the efficacy 
achieved with free GSI delivery. Rizzo et al. recently reported that mice with 
MDA-MB-231 tumors, consisting of cells expressing high intrinsic Notch ac-
tivity, were treated by p.t. injections of 1.2 mg/kg GSI every second day for 2 
weeks which led to reduced tumor growth.174 Here, GSI loaded particles were 
administered 1 mg/kg GSI every 3rd day for 12 days after which the treatment 
was terminated and the mice were left untreated for an additional 2 weeks. 
According to the obtained results in our study, treatment with GSI loaded par-
ticles clearly reduced tumor growth and the effect was detectable even 2 weeks 
after the last injection (Figure 66a). In contrast to the same administration pro-
cedure of free GSI had no effect on tumor growth (Figure 66b). Consequently, 
the levels of Notch intracellular domain were clearly reduced (inhibition of 
Notch activity) in tumors treated with GSI-loaded particles as compared to tu-
mors treated with control particles, analyzed by western blotting (Figure 66c). 
17.6. Evaluation of the biocompatibility of MSNs adminis-
tered through the intravenous and peritumoral routes 
In order to evaluate the biocompatibility of the developed MSNs, the particles 
were tracked both after p.t. (20 mg/kg) (Figure 67) and after intravenous (i.v.) 
(20 mg/kg) administration (Figure 68). 
Within a few hours after the p.t. injection, a strong fluorescent signal was 
shown in the bladder, which indicates urine excretion of non-retained particles 
(Figure 67a). Further, at the 48 h time point, the signal in the bladder had re-
duced below the detection limit, indicating that the majority of particles which 
were not taken up by the cancer cells were eliminated within 2 days. This was 
supported also by particle dissolution tests in biological media, demonstrating 
70 % reduction of the particle mass of MSNs in 50 h (Figure 70). The biodegra-
dation and renal excretion were further supported by the inductively coupled 
plasma and optical emission spectrometry (ICP-OES) analyzes of the silica 
content in the urine collected from the mice at 4 and 24 h time points after i.v. 
injection (Figure 71). However, particles that were uptaken by cells dissolved at 
a slower rate107 and 72 h after injection FA-conjugated particles or parts of them 
were still observed in the tumors. 
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After i.v. injections (20 mg/kg) tumor accumulation was observed within 
12 h, and they remained visible at the tumor site at 120 h (Figure 68). The 
reported specific tumor accumulation was further determined and supported 
by ex vivo analyses of isolated organs at 196 h after particle administration 
(Figure 69b). Furthermore, to analyze the significance of active targeting, the 
signal was quantified at 72 h time point after injection ex vivo in organs of ani-
mals that had injected i.v. with PEI-MSNs and FA-MSNs.
Both particles with the targeting function (FA-MSNs) and particles lack-
ing the targeting ligand accumulated preferably to tumors. This phenomenon 
can be interpreted as a sign of passive targeting. Generally, after 72 h the tar-
geted and non-targeted particles showed quite similar distribution in vivo. 
Figure 66. DAPT-loaded mesoporous silica nanoparticles (MSNs) block Notch 
activity, inhibit tumor growth, and control stem cell functions in vivo. a) MDA-
MB-231 tumor-bearing mice were injected p.t. with FA-conjugated GSI-loaded 
(GSI-MSN, 20 mg/kg, 2.5 wt-% GSI) and empty MSNs were used as a control 
(Ctrl-MSN, 20 mg/kg) up to 12 days. The tumor size was followed for 3 weeks (n = 
6, mean ± SD) (**P < 0.011). b) MDA-MB-231 tumor-bearing mice were injected 
p.t. with 1 mg/kg free DAPT or the DMSO aqueous vehicle solution (Vehicle) 
up to 12 days. The tumor size was followed until day 22 (n = 4, mean ± SD). c) 
p.t. treatment of GSI-MSN leads to reduced active Notch levels of in the tumors, 
as demonstrated by western blotting. Here Notch was detected by an antibody 
recognizing the intracellular domain (NICD), the active form of Notch. 
Summary of the results
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Figure 67. MSNs accumulate in the tumors. They are biocompatible, bio-
degradable, and mainly eliminated through renal excretion. a) In vivo imaging of 
mice injected p.t. with PEI-MSNs or FA-PEI-MSNs. IVIS images of the abdominal 
area show accumulation of fluorescence in the bladder and imaging of the dorsal 
area presents accumulation of fluorescence in the tumors. Fluorescence was 
eliminated from the bladder within 48 h after the injections (number of animals 
per group, n = 4, two tumors per animal). b) i.v. administration of FA-MSNs. Ex 
vivo images of organs (on the left) and fluorescence intensity quantification (on 
the right). All examined animals were killed 196 h after injection (n = 4). Please 
note the occasional signal from the brain tissue. This is most likely background 
fluorescence, as it is present also in untreated control animals. (c) The conducted 
histological analysis of brain, kidney, spleen, liver, and lungs of untreated mice 
and FA-MSNs-treated mice. This showed no morphological changes. All animals 
were killed 192 h after i.v. injection.
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Figure 68. Particles admininstered through i.v. injections (20 mg/kg) show positive 
tumor accumulation. Particles remained visible at the tumor site up to 120 hours 
after administration.
Figure 69. The targeted and non-targeted particles were determined to have 
quite similar in vivo distribution at 72 hours time point after i.v. injection. Both 
particles showed signs of renal excretion.
Figure 70. Dissolution of MSNs 120 μg ml-1 in 25 mM HEPES buffer (pH 7.2, 
37 °C) as a function of time.
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Both particles appeared to be biodegradable and were eliminated with the ex-
ception of accumulation of FA-tagged particles in the lungs (Figure 68). How-
ever, in 196 h the fluorescent signal from the lungs in the mice injected with 
FA-MSNs was no longer detectable, which supports the efficient biodegrada-
tion and elimination of the particles. 
Moreover, mice treated with FA-MSNs showed no pathological abnormali-
ties in major organs (Figure 67d). Eight days after i.v. administration, a gross 
histology of brain, liver, spleen, kidneys, and lungs isolated from treated and 
control mice was concluded to be identical (Figure 67c). Generally, the animals 
tolerated particle treatment well and the body weigh of the mice did not change 
during treatment; there were, moreover, no signs of reduced food intake, im-
paired mobility or visible infections. As the kidneys through the urine excre-
tion were determined to be the main route of elimination, kidney function was 
analyzed by measuring serum creatinine levels in untreated mice and in mice 
treated with PEI-MSNs or FA-MSNs. Significant elevation of creatinine levels 
was detected, which indicates that kidney function was not impaired. 
Figure 71. ICP-OES analyzes of the silica content in the urine of mice. Samples 
were collected at 4 and 24 h time points after i.v. injection. The silica concentration 
in urine increases with time, which supports the biodegradation of particles and 
their renal excretion.
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17.7. Summary of the results
In this study, the targetability of MSNs was demonstrated both in vitro and in 
vivo. The GSI-loaded MSNs showed therapeutic efficacy through targeted in-
hibition of gamma secretase leading to reduced Notch signaling activity, which 
was seen as a halt of the tumor growth in vivo. The enhanced therapeutic effi-
cacy was evaluated by using a free drug at the corresponding concentrations as 
a control. MSNs-mediated GSI delivery in vivo provided a significant therapeu-
tic benefit compared to free drug administration, as the free drug was virtually 
noneffective at inhibiting tumor growth. An added value of the particle-me-
diated drug delivery is the possibility of using lower drug concentrations and 
a dosing with lower frequency compared to the administration of a free drug. 
These results are encouraging also on a general level, as using MSNs as delivery 
vehicles for GSI, or any other drug, especially those with severe side effects, 
may also allow for the use of drug concentrations below the systemic toxicity 
limit. Moreover, the MSNs were shown to be biocompatible, biodegradable, 
and eliminated mainly by renal excretion.
Summary of the results
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Conclusions and outlook
Silica nanoparticles with targeting and tracing functions were prepared; the 
functionalities were confirmed both in vitro and in vivo. Furthermore, stud-
ies related to the biocompatibility and dispersion stability of the particles in 
biomedical conditions supported the potential of versatile silica platforms for 
personalized medicine. 
The properties of nanoparticles are highly size-dependent, and thus good 
dispersion stability is a prerequisite for an active theranostic agent. Particle 
physico–chemical characteristics such as the surface functionalization have 
high influence on the colloidal properties, which is seen from the provided re-
sults indicating that the stability of the particle suspensions is crucially depend-
ent on all functional groups present on the particle surface. It was shown that 
by the proper choice of surface functionalization route, traceable streptavidin 
conjugated particles, stable in physiological conditions can be prepared. The 
added value of conjugating streptavidin on the particle surface is its exception-
ally high affinity to its water-soluble ligand biotin (vitamin H), which enables 
its binding to a wide variety of biotin-antibody complexes and further targeting 
of nanoparticles to cell receptors of interest.
The biomedical environment consists of aqueous media and therefore ther-
anostic agents should possess hydrolytic stability in a magnitude that enables 
the particles to remain stable (intact) in the body the time scales needed to 
accomplish their task, followed by dissolution and degradation of the parti-
cle matrix. Therefore targeting groups should stay on the particle surface until 
the particles have been internalized, after which the degradation should take 
place to facilitate the release of the particle-incorporated drug and to prevent 
particle material-induced toxicity. The degradation of silica nanoparticles was 
evaluated by preparing a model particle in which all particle functionalities 
were labeled with a different fluorophore. The particle design, together with 
light microscopy and image analysis, enabled a detailed study of the degrada-
tion process in vitro, thus supporting the biocompatibility of silica particles in 
nanomedicine. The obtained results clearly suggest that the PEI layer, modeling 
generally the particle functionalities, is detached from the rest of the particle, 
most probably both in the form of free PEI and PEI attached to fragments of 
the outmost particle structure, in this case mesoporous silica. This degrada-
tion process was preferentially detected inside the cells. These results further 
suggested that covalent attachment of drugs, targeting groups, or other func-
tionalities and their subsequent intracellular detachment is a promising route 
towards intrinsically-triggered intracellular release. These results also demon-
strated new imaging-based methodology that can be used to effectively analyze 
the degradation of nanoparticles inside cells.
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Silica nanoparticles were successfully targeted and also simultaneously used 
to deliver therapeutic agents in vitro and in vivo. Nonporous nanoparticles us-
ing monoclonal antibodies as guiding agents were examined in vitro to study 
their targetability and internalization. In addition to successful targetability, 
a specific cell entry route was detected. In a separate study, in vivo-traceable 
mesoporous nanoparticles loaded with a hydrophobic cancer drug conjugated 
with a small molecular targeting ligand was demonstrated for in vitro- and in 
vivo-targeted drug delivery. Drug-characteristic pathway inhibition was ob-
served, which led to enhanced tumor shrinkage and to a significantly improved 
therapeutic outcome. The enhanced therapeutic efficacy of particle-mediated 
delivery was evaluated by using a free drug at corresponding concentrations 
as a control. The particle-mediated drug delivery in vivo was reported to pro-
vide a significant therapeutic benefit compared to an administered free drug. 
Moreover, the demonstrated therapy of using mesoporous silica nanoparticles 
was shown to be biocompatible, biodegradable, and eliminated mainly by renal 
excretion.
It would, in the future research, be attractive to optimize in vivo biodistri-
bution of particles aimed for theranostics. Preparing traceable and targetable 
silica nanoparticles for biomedical use would require special attention to be 
paid on particle dispersion stability, biocompatibility and targeting capabilities 
to optimize their use in biological systems, similar to the present study. Particle 
functionalization could provide new means for instance to control the protein 
adsorption on the particles and particles’ interaction with RES. One very im-
portant parameter controlling the biodistribution is the particle size. Mono-
clonal antibodies are a group of very versatile ligands “allowing specificity to 
almost any extracellular cell-surface target” and thus targeting using mAb’s 
would be attractive also in the future research.
Conclusions and outlook
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